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ABSTRACT 
This study further characterized a newly discovered interaction of two nutrients, 
choline and carnitine. Increased dietary choline had previously been demonstrated to 
cause a conservation of carnitine in humans and guinea pigs, and an increased muscle 
carnitine concentration guinea pigs. The first part of this study compared the effect of 
varied doses of choline on urinary excretion of carnitine, tissue and whole body 
carnitine concentrations, and body composition. It was demonstrated that a choline 
dose of 2 g/kg diet results in a near maximal effect on urinary conservation of 
carnitine, which is mediated by an increase in the fractional tubular reabsorption of 
carnitine. There was also a dose dependent decrease in the ratio of fat/protein of 
carcasses of choline supplemented animals. The second part of the study evaluated 
functional consequences of the choline-carnitine interaction. Indirect calorimetry was 
used to evaluate energy substrate utilization in choline supplemented (3 g/kg diet) and 
nonsupplemented guinea pigs. There was no effect of choline supplementation on 
fatty acid oxidation in the guinea pigs when fed, unfed, or during treadmill exercise. 
The mechanism of how choline supplementation affects body fat composition in 
guinea pigs remains unknown, but appears to be independent of effects on capacity 
for fatty acid oxidation. 
iii 
TABLE OF CONTENTS 
CHAPTER PAGE 
1. Introduction .................................................................................................... 1 
2. Literature Review ............................................................................................ 3 
Choline ...................................................................................................... 3 
Carnitine ................................................................................................... 9 
Camitine-Acyltransferases ....................................................................... 21 
Interactions Between Nutrients ................................................................ 28 
3. Preliminary Research and Objectives ............................................................. 3 2 
4. Effect of Varied Choline Dose on Plasma, Urinary and Tissue Camitine 
in Guinea Pigs ............................................................................................... 3 9 
Introduction ............................................................................................ 3 9 
Materials and Methods ............................................................................ 41 
Results .................................................................................................... 50 
Discussion ............................................................................................... 65 
Conclusions ............................................................................................. 71 
5. Metabolic Consequences of Choline-Carnitine Interactions ............................ 73 
Introduction ............................................................................................ 73 
Materials and Methods ............................................................................ 77 
Results .................................................................................................... 87 
Discussion ........................................................ ....................................... 97 
Conclusions ............................................................................................ 103 
References ........................................................................................................... 104 
Appendixes ......................................................................................................... 120 
Vita .................................................................................................................... 139 
iv 
LIST OF TABLES 
TABLE PAGE 
2-1 Steps in the Biosynthesis of Carnitine, and Nutrients Required ...................... 13 
3-1 Liver Choline Oxidase in Selected Species .................................................... 33 
3-2 Effect of Choline Supplementation on Urinary Excretion and Plasma 
Camitine Concentration of Camitine in Guinea Pigs ..................................... 3 5 
4-1 Composition of Guinea Pig Semi-Purified Diet ............................................. 42 
4-2 Food Consumption and Weight Gain or Loss in Guinea Pigs Fed 
Ground Commercial Diet or Semi-Purified Diet ............................................ 43 
4-3 Choline Content of Control and Experimental Guinea Pig Diets .................... 45 
4-4 Feed Consumption, Weight Gain, and Feed Efficiency in 
Choline Supplemented and Non-Supplemented Guinea Pigs ......................... 51 
4-5 Urinary Excretion of Camitine in Guinea Pigs Supplemented with 
Varied Levels of Choline for 21 Days ........................................................... 52 
4-6 Plasma and Tissue Concentrations of Camitine in Guinea Pigs 
Supplemented with Varied Levels of Choline for 21 Days ............................. 54 
4-7 Intestinal Lumen Content and Feces Concentrations of Camitine 
in Guinea Pigs Supplemented with Varied Levels of Choline for 21 Days ...... 58 
4-8 Body Composition of Guµiea Pigs Supplemented with Varied 
Levels of Choline for 21 Days ...................................................................... 59 
4-9 Total Body Camitine and Urinary Conservation of Carnitine in Guinea Pigs 
Supplemented with Varied Levels of Choline for 21 Days ............................. 63 
4-lOEffects of Varied Levels of Choline Supplementation on Renal Excretion 
and Reabsorption of Camitine and Creatinine ............................................... 64 
V 
TABLE PAGE 
5-1 Review of Carnitine Supplementation and Exercise ...................................... 74 
5-2 Choline Content of Guinea Pig Diets and Initial and Body Weights ............... 79 
5-3 Urinary Excretion of Carnitine in Guinea Pigs With or Without 
Choline Supplement in Fed and Unfed States ................................................ 91 
5-4 Final Plasma Concentrations and Urinary Excretion of Carnitine in Control 
or Choline Supplemented Guinea Pigs in Fed or Unfed States ....................... 94 
5-5 Tissue Concentrations of Carnitine in Guinea Pigs Fed Diets With 
or Without Supplemental Choline in Fed or Unfed States ............................. 95 
vi 
LIST OF FIGURES 
FIGURE PAGE 
2-1 Role of carnitine in the translocation of acyl groups across the inner 
mitochondrial membrane into the mitochondiral matrix for oxidation . .......... 17 
3-1 Effect of choline supplementation on tissue concentrations of total 
carnitine in guinea pigs . ................................................................................ 3 7 
4-1 Camitine concentrations in proximal (A), middle (B), distal (C), or average 
of all segments of the small intestine of guinea pigs given varied levels or no 
supplemental choline added to ground diet for 21 days ................................. 5 7 
4-2 Regression analysis of the effect of varied levels of choline 
supplementation on % body fat (top) and the ratio of % fat / %protein 
(bottom) in whole body homogenates of guinea pigs ................................... 61 
5-1 Pre-experimental diet respiratory exchange ratios and 
oxygen consumption. . ................................................................................. 88 
5-2 Post-experimental diet respiratory exchange ratios and 
oxygen consumption ................................................................................... 89 
5-3 Respiratory exchange ratio of choline supplemented (ChS) or 
non-supplemented (NS) guinea pigs running on a treadmill at a speed 
of 15m/min and an incline of 5%/ ................................................................. 92 
5-4 Activity of CPT (top) in liver of non-supplemented (NS) or choline 
supplemented (ChS) guinea pigs fed or unfed for 24h . .................................. 98 
A-1 Equipment setup for gas analysis .................................................................. 130 
vii 
Chapter 1 
Introduction 
Two molecules are of primary importance in the research presented here: choline, 
and carnitine. Choline and carnitine are both common constituents of most diets, but 
carnitine is not an essential nutrient and choline is not universally recognized as 
essential (Rebouche 1986 and Zeise] et al. 1991 ). 
We have previously shown that choline supplementation, results in a substantial 
decrease in the urinary excretion of carnitine in humans (Daily and Sachan 1995, 
Dodson and Sachan 1996). The decreased excretion of carnitine was accompanied by 
variable changes in plasma carnitine concentrations, and it was concluded that there 
was no significant effect on plasma carnitine concentrations. In rats, carnitine 
excretion was unaffected by choline both in our studies and those of others (Daily and 
Sachan 1995, Sheard et al. 1992). Guinea pigs, however, did exhibit a pattern of 
carnitine excretion similar to that of humans during choline supplementation, but had 
an increased plasma carnitine concentration, unlike humans. We have attributed the 
lack of effect in rats to the high choline oxidase activity in rat liver, 60 fold higher 
than that in humans and 20 fold higher than that guinea pigs (Sidransky & Farber 
1960). 
I 
There are several possible explanations for the decreased excretion of carnitine 
during choline supplementation. Absorption of dietary carnitine could be impaired and 
less carnitine available to be excreted. The guinea pig diet, however, did not have 
enough carnitine to be detectable and should not have been able to contribute enough 
carnitine to be significant. Choline may have impaired the biosynthesis of carnitine, 
but that seems unlikely because choline deficiency results in a carnitine deficiency 
(Carter & Frenkel 1978) and excess has not been shown to impair synthesis. Another 
likely explanation is that carnitine is being redistributed among body pools with some 
tissues taking up carnitine. If this were the case, it might indicate an i�creased need 
for carnitine in the affected tissues and be an indicator of increased fatty acid 
oxidation or at least an increased capacity for fatty acid oxidation. 
Choline and carnitine are all sold as supplements in the United States. Any 
interaction between them that might affect the status of the other would have 
significant implications. We have demonstrated that choline does affect carnitine 
homeostasis. In guinea pigs this has been demonstrated at a level of 3 g/kg diet of 
supplemental choline. The first study presented here is a dose response study to 
determine what levels of supplementation are required for a maximal effect of choline 
on urinary carnitine excretion and carnitine concentrations in guinea pig plasma and 
tissues. Because of the obligatory role of carnitine in the oxidation of fatty acids, the 
second study investigates the physiological consequences of choline supplementation 
on fat metabolism in guinea pigs. 
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Chapter 2 
Literature Review 
Choline 
Choline is a quaternary trimethylated amine as is carnitine, another nutrient of 
primary importance in this research. Choline is synthesized de novo in humans, but is 
also widely available in the diet. Choline deficiency has been induced in animals 
resulting in liver damage, renal hemorrhage, and inability to export triglyceride from 
the liver, thereby causing hepatic fat accumulation (Kuksis & Mookerjea 1984). There 
has never been a case of choline deficiency syndrome observed in humans, probably 
because of its ubiquitous nature in the human diet. 
Choline in the diet: 
Daily dietary intake of choline is estimated at between 600 and 900 mg/day 
(Kuksis A. & Mookerjea 1984). Choline is available from dietary sources both as 
choline chloride and as phosphatidylcholine (lecithin). The best dietary sources of 
choline include meat, eggs, oatmeal, soybeans, wheat germ, peanuts, and other nuts 
and grains (Zeisel 1981). The most abundant form of choline in the diet is lecithin, but 
many foods contain significant amounts of choline chloride, especially liver and 
soybeans. Choline is also obtained in the diet from sources other than naturally 
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occurring foods. Lecithin is a common food additive because of its ability to emulsify 
fats. It is a major ingredient in frying pan sprays, and is available as a nutritional 
supplement as either lecithin or choline chloride. 
Non dietary sources of choline: 
Lecithin is formed in mammals by three different pathways; the base exchange 
pathway, CDP-choline pathway, and the methyltransferase pathway (Zeisel 1981 ). 
The base exchange pathway simply exchanges choline for another base on a 
phospholipid. The CDP-choline pathway uses diacylglycerol and pre-existing choline 
to form phosphatidylcholine. The methyltransferase pathway is the only way that new 
choline is produced. In the methyltransferase pathway phosphatidylethanolamine is 
sequentially methylated by phosphatidylethanolamine-N-methyltransferase (PEMT) 
using S-adenosyl methionine (SAM) as the methyl source (Bjoranstad P. & Bremer J. 
1966 and Lindblad L. & Schersten T. 1976). PEMT is most concentrated in the liver 
but is also found in the kidney, testes, heart, lung, adrenal gland, erythrocytes, spleen, 
and brain (Blusztajn J.K. et al. 1979, Hirata & Axelrod 1978, and Hirata et al. 1978). 
In the rat about 15% of the choline requirement is supplied by the methyltransferase 
pathway, and the remainder obtained from the diet (Zeise} 1981, Scheneider & Vance 
1979, and Wise & Eleyn 1965). Human requirements for dietary choline, if any, are 
not yet determined. 
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Choline in single carbon metabolism: 
Choline is frequently referred to as an important source of labile methyl groups 
(Zeisel & Da Costa 1991). SAM is the active agent in many synthesis reactions 
requiring the addition of a methyl group. When SAM donates it methyl group it is 
hydrolyzed to form homocysteine and adenosine. The methionine may be regenerated 
by the transfer of a methyl group from either N5 - methyl tetrahydrofolate or betaine. 
Both sources are of about equal importance in the rat (Finkelstein & Martin 1984). 
Choline supplementation in rats has been shown to prevent pathology of folate 
deficiency for up to three months (Aarsaether et al. 1988). Although choline is a 
significant contributor of methyl groups in rats, its significance in humans is 
questionable. The only way for choline to be used as a methyl source is for it to first 
be oxidized to betaine. Human liver has only 1/60 of the choline oxidase activity of rat 
liver (microliters of 02 uptake/brig wet liver) (Sidransky & Farber 1960). All studies 
of choline as a methyl donor have used rats as an animal model and may not apply to 
humans. However, even if humans do not utilize choline as a methyl donor, there are 
other critical functions for choline in humans. 
Functions of choline in humans: 
The central nervous system requires choline for the synthesis of the important 
neurotransmitter, acetylcholine. Acetylcholine is important for communication 
between neurons in the central nervous system (CNS) and is also the neurotransmitter 
5 
used for communication between the CNS and somatic motor neurons. Acetylcholine 
is synthesized by the transfer of an acetyl group from acetyl coenzyme-A (CoA) to 
choline in a reaction catalyzed by the enzyme choline acetyltransferase. Enzyme 
kinetic studies of choline acetyltransferase in brain tissue suggest that the enzyme is 
unlikely to ever be saturated, and that the rate of acetylcholine synthesis is controlled 
by the availability of choline and/or acetyl CoA (White and Wu 1973). It has been 
demonstrated that administration of choline simultaneously with an inducer of 
cholinergic activity (3, 4-diaminopyridine) increases the synthesis and release of 
acetylcholine in rats and that the two act synergistically for the greatest effect 
(Buyukuysal, R.L. et. al. 1995). 
Choline, as phosphatidylcholine and sphingomyelin, is a major structural 
component of cell membranes. Phosphatidylcholine accounts for approximately 50% 
of all cell membrane phospholipids and sphingomyelin 5-20% depending on the cell 
type (Zeisel 1993). 
Phosphatidylcholine is an important source of diacylglycerol used in maintaining 
active protein kinase C within cells. The activation of protein kinase C is mediated by 
binding to calcium and diacylglycerol in most isotypes, but some require only 
diacylglycerol (Nishizuka 1992 and Exton 1990). Choline is also a part of the 
membrane phospholipid, spingomyelin, which is involved in intracellular signaling. 
Sphingomyelin is hydrolyzed to form ceramide and choline phosphate in response to 
several known factors including l-a,25-dihydroxyvitamin D, tumor necrosis factor, 
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and y-interferon (Merril 1992). Ceramide is a potent inhibitor of cell growth and 
sphingosine an inhibitor of protein kinase C (Merril & Stevens 1989 and Merril & 
Jones 1990). Choline itself has not yet been reported to be a signal transduction 
molecule and its function, if any, when choline containing phospholipids are 
hydrolyzed, is unknown. 
Choline, an essential nutrient: 
Choline has been shown to be an essential nutrient in many species including rat, 
hamster, guinea pig, pig, dog, monkey, trout, and chicken (Finkelstein et al. 1982). 
Choline deficiency results in spontaneous liver cancer in rats without exposure to 
known carcinogens and is the only nutrient whose deficiency is known to result in 
spontaneous malignancies (Newbeme & Roger 1990, and Zeisel 1993 ). Choline 
deficiency, in species for which it has been shown to be essential, can result in 
impaired hepatic, renal, and pancreatic function; memory loss, and decreased growth 
(Finkelstein et al. 1982). It has been difficult to demonstrate that choline is an 
essential nutrient for humans; however, it has been shown that human cells grown in 
culture have an absolute requirement for choline (Eagle 1955). Malnourished humans 
have decreased serum choline concentrations and parenterally fed persons without 
choline supplementation develop abnormal liver function, indicating that there may be 
a requirement for choline in the diet {Tayek et. al. 1990). 
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Zeisel et al. ( 1991) conducted a human study in which the experimental group 
received an artificial diet free of choline and a control group which received an 
identical diet, except with added choline. They found decreased choline and 
phosphatidylcholine in the plasma as expected, but also, the serum alanine 
aminotransferase activity increased consistently over the three weeks in the choline 
deficient group, and the study was terminated to avoid risk to the subjects. 
A common problem among patients on long-term total parental nutrition (TPN) is 
hepatic steatosis accompanied by lower than normal plasma choline concentrations 
(Buchman et. al. 1992, Buchman et. al. 1993). A study of 4 patients receiving long­
term TPN (9. 7 ± 4. 7 years) who had low plasma choline concentrations as well as 
hepatic steatosis, evaluated choline supplementation as a treatment for the steatosis 
(Buchman et. al. 1995). The degree of hepatic steatosis was determined by the use of 
abdominal computed tomography (CT) before beginning the choline supplementation, 
and after 2 and 6 weeks of supplementation. Liver density, in Hounsfeld units (HU) 
can be used to estimate the degree of steatosis, since fat is less dense than lean tissue. 
Liver density in the patients increased from -14.2 ± 22.3 HU at the beginning of the 
study to 8.4 ± 10.3 HU after 2 weeks, and 9.6 ± 10.7 HU after 6 weeks. After 6 
weeks of choline supplementation, there was essentially no hepatic steatosis in the 
patients. 
Pregnancy and lactation are also conditions that may be associated with 
compromised choline status. A choline deficient diet in both pregnant and lactating 
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rats results in significant decreases in liver phosphorylcholine, betaine, and free 
choline as compared to non-pregnant/non-lactating rats on a choline deficient diet 
(Zeisel, S.H, et. al. 1995). This demonstrates that pregnancy and lactation result in 
increased risk for choline deficiency in rats. However, this has yet to be demonstrated 
in humans. 
Impairment of liver function seems to be consistent among all species, including 
humans, during choline deficiency. It has been difficult to find cases of choline 
deficiency in human populations because choline is plentiful in foods. It would be 
difficult to construct a diet of natural foods that is choline deficient, this does not 
mean, however, that choline is not essential - just easily obtained. Studies with 
artificial diets suggest that choline may be an �ssential nutrient. 
Camitine 
L-camitine, L-f3-hydroxy-y-N-trimethylaminobutyric acid, like choline is a 
quaternary, trimethylated amine. Camitine, again like choline, is synthesized de novo 
in humans, and is available in the diet, though not as plentifully as choline (Broquist 
1994). Carnitine was originally called vitamin BT but this terms is no longer used since 
carnitine is not considered essential in the diets of higher organisms. Diseases of 
camitine deficiency have been identified in humans (Broquist 1994), however, and 
will be discussed later. 
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Carnitine in the diet: 
Dietary carnitine is derived primarily from animal food sources, and the average 
nonvegetarian diet is estimated to supply 100-300 mg of carnitine per day (Broquist 
1994). Vegetables, fruits, and grains are very poor sources of carnitine. Ground beef 
has about 580 µmol of camitine per 100 grams whereas asparagus (one of the richest 
vegetable sources) has about 1 .2 µmol per 100 grams (Broquist 1994, Moukarazel et 
al. 1992}. 
Dietary intake of carnitine has been shown to have a significant influence on 
carnitine status in humans. Children receiving total parenteral nutrition for 7.2 ± 2.6 
years from birth had total plasma carnitine concentrations approximately half that of 
other children of similar age (Moukarazel et al. 1992). When adults and children eat 
either strict vegetarian diets, lacto-ovovegetarian diets, or mixed diets (including meat) 
for long periods of time, both plasma camitine and urinary excretion of carnitine have 
been shown to be affected (Lombard et al. 1989). Differences in plasma camitine 
concentrations between groups were small but significantly lower in vegetarians. 
Differences in urinary excretion of camitine were much greater, adult men on mixed 
diets, lactoovovegetarian diets, or strict vegetarian diets excreted 5.79 ± 3.08, 2. 1 ± 
0. 76, and 1.36  ± 0.49 µmol camitine per kg body weight per day, respectively. Similar 
trends were seen for male children as well as female adults and children. The urinary 
excretion of carnitine decreased proportionately with predicted carnitine intake. The 
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subjects eating diets highest in carnitine had the highest excretion rate and those with 
diets lowest in carnitine (strict vegetarian) had the lowest excretion rate. 
How the differences in plasma carnitine and urinary carnitine excretion correlate 
with tissue concentrations is not certain. It has been shown in rats that dietary 
differences do substantially affect tissue concentrations, but were roughly proportional 
to plasma concentrations, which had a much greater variation than seen in the above 
mentioned human study (Negaro et al. 1987). 
To what extent humans rely on dietary carnitine is unknown. Cederblad and 
Lindsted (1976) report that synthesis contributes four times more carnitine than does 
diet in laboratory rats. In humans, however, dietary intake may be more important 
since diet typically contributes 1 00-300 mg per day. The functional consequences of 
variations in dietary intake of carnitine in humans are not known at this time, but it is 
clear that dietary intake can affect plasma carnitine concentrations in humans and both 
plasma and tissue concentrations in rats. 
Intestinal absorption and tissue uptake of carnitine: 
It has been difficult for researchers to determine the percentage of carnitine 
absorbed from the diet. It was assumed for many years that carnitine was nearly 100% 
absorbed because when labeled carnitine was given orally, little radioactivity appeared 
in the feces. Kinetic analysis in animals and humans, however, indicated that there was 
a higher rate of excretion than was reported (Brooks & McIntosh 197 5, Rebouche & 
1 1  
Chenard 199 1 ,  Rebouche & Engel 1983). In the kinetic studies, the carnitine was 
given intravenously and no metabolites of carnitine were found in urine or feces. 
However, when radioactively labeled carnitine was fed orally to rats as much as 34% 
of the radioactivity was found in excreted metabolites (trimethylamine N-oxide and Y­
butyrobetaine) of carnitine in urine and, to a small extent, in feces (Rebouche et al. 
1984). When humans are fed radioactive carnitine 95% of the radioactivity is absorbed 
from the intestinal tract, but several metabolites show up in the urine, primarily 
trimethylamine N-oxide (Rebouche & Chenard 1 991 ). Apparently intestinal bacteria 
degrade carnitine to other metabolites which are in tum absorbed and then excreted in 
the urine. Recent studies indicate that carnitine is 54-87% absorbed without 
degradation, depending on the dosage (Rebouche & Chenard 1 99 1  ). 
Carnitine is absorbed both actively and passively across the intestinal mucosa 
(Broquist 1994). Active carnitine absorption is a sodium-linked process similar to the 
absorption of phosphate (Cheng & Sacktor 1 98 1 ,  Hamilton et al 1983, Stadler et al. 
1 993 .) .  Carnitine enters the blood stream via the portal circulation and circulates as 
free or acyl camitines (Broquist 1994). Most tissue cells transport camitine against a 
concentration gradient resulting in a 1 0- 100 fold greater intracellular concentration 
(Broquist 1 994 ), suggesting an active transport mechanism. 
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Carnitine biosynthesis: 
Carnitine is synthesized from two essential amino acids in all mammals including 
humans (Bieber 1988). The nitrogen and carbon backbone of carnitine is derived from 
lysine, and the methyl groups attached to the nitrogen originate from SAM. Table 2-1 
shows the steps in carnitine biosynthesis, and the nutrients required as cofactors 
(Broquist 1994, Cederblad et al. 1979, Henderson et al 1982, Lindstedt et al 1970, 
Hulse and Henderson 1980). 
Step 
1 .  
2. 
3 .  
4. 
5. 
Table 2-1 
Steps in the Biosynthesis of Camitine, and Nutrients Required 
Reactant Product Required Nutrient 
Lysine N-trimethyl-lysine Methionine, Lysine 
N-trimethyl- N-trimethyl-3- Vitamin C, Iron 
lysine hydroxylysine 
N-trimethyl- 4-N-trimethylamino Vitamin B6 
3-hydroxylysine butryaldehyde 
4-N-trimethylamino 4-N-trimethylamino Niacin 
butyraldehyde butyric acid 
4-N-trimethylamino L-carnitine Vitamin C, Iron 
butyric acid 
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In step 1 lysine is methylated as a post-translational modification in proteins including 
actin, myosin, and histones; and N-trimethyl-lysine is released as a result of enzymatic 
degradation of those proteins (Broquist 1994, Broquist 1982, LdaBadie et al. 1976). 
Steps 2-5 in Table 2-1 occur in both the liver and kidney in higher mammals (Broquist 
1982, Sachan & Hoppel 1980, Rebouche and Engel 1980). 
It is not clear how much effect diets deficient in the nutrients involved in camitine 
biosynthesis have on camitine status. Wheat gluten diets ( deficient in lysine) have little 
effect on camitine concentrations in adult rats (Sachan & Mynatt 1993), however, 
weanling rats fed a lysine deficient diet will become carnitine deficient (Khan & Bamji 
1979, Tanphaichitr & Broquist 1973). 
Vitamin C deficiency has also been proposed to impair carnitine status since it is 
required for its biosynthesis. Vitamin C deficiency has been shown to result in 
decreased activity of hepatic y-butyrobetaine hydroxylase and hepatic and renal a-N­
trimethyllysine hydroxylase (Rebouche 1991 ). It was not determined, however, if the 
effect on enzyme activity altered carnitine status. A subsequent study (Rebouche 
1 995) demonstrated that tissue camitine concentrations were reduced in scorbutic 
guinea pigs, and that urinary excretion of carrutine was increased. However, 
supplements ofradioactive tracers of the camitine precursor, e-N-trimethyllysine, were 
converted to camitine more rapidly in the scorbutic guinea pigs than in controls. It was 
concluded, therefore, that vitamin C deficiency causes camitine depletion by increasing 
urinary excretion of carnitine and not by inhibiting its synthesis. 
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Iron also has an obligatory role in camitine synthesis and a deficiency could impair 
the process. Nutritional iron deficiency in pregnant rats results in hypertriglyceridemia 
in both mother and pups, which can be reversed with iron supplementation (Sherman 
et al. 1982). Pregnant rats continued on a iron deficient diet into the lactation period 
produce milk with normal carnitine concentrations but reduced iron concentrations 
(Bartholemy & Sherman 1985). On day 2 after birth there was no difference in 
carnitine concentrations in the pups, but on day 1 6  liver carnitine was about half that 
of iron sufficient pups. Rat pups are not fully able to synthesize carnitine until 8 days 
after birth (Hahn 1981 ), so the effect of iron deficiency on their own camitine 
synthesis would not be expected to be seen very soon after birth. 
Marzo et al. ( 1994) found that plasma concentrations and urinary excretion of 
camitine progressively decreased significantly in pregnant women. Plasma 
concentrations dropped to approximately half the normal values for the same subjects 
by week 3 6 of the pregnancy. The decreased plasma carnitine concentrations were 
restored without intervention by one month after giving birth. These studies 
demonstrate that iron deficiency may result in impaired carnitine synthesis and may 
also explain the hypertriglyceridemia seen in the iron deficient pups. 
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Carnitine and /atty acid metabolism: 
The transport of long chain fatty acids across the inner mitochondrial membrane 
into the matrix of the mitochondria (Figure 2-1) is the best characterized function of 
carnitine (Fritz 1 963). This process involves the activation of a fatty acid by coupling 
to coenzyme A via a thioester bond, followed by transfer of the acyl group to 
carnitine, translocation of the acylcarnitine across the inner membrane, and transfer of 
the acyl group to intramitochondrial CoA (Beiber 1988). The first step in carnitine 
mediated transport of fatty acids across the inner mitochondrial membrane is the 
cytosolic generation of acyl CoA which diffuses across the outer membrane into the 
inter membrane space. 
Carnitine palmitoyltransferase I (CPTl)  spans the outer mitochondrial membrane, 
with the transferase active site on the inside of the membrane and a malonyl CoA 
binding site on the cytosolic side. The active site transfers the acyl group of the acyl­
CoA to carnitine to make an acylcarnitine (Bremer 1983). Binding of malonyl CoA to 
the cytosolic side of the CPT 1 inhibits the enzyme and assures that acyl groups will 
not be transported into the mitochondria for oxidation at the same time that fats are 
being synthesized (Brady et al 1993). Carnitine-acylcarnitine translocase shuttles the 
acylcarnitine across the inner mitochondrial membrane where another CPT (CPT2) 
transfers the acyl group back to intramitochondrial CoA after which it proceeds to 
oxidation (Broquist 1994). The reverse of the process for transporting long chain 
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Figure 2-1 :  Role of camitine in the translocation of acyl groups across the inner 
mitochondrial membrane into the mitochondiral matrix for oxidation. 
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fatty acids into the mitochondrial matrix appears to be used for removing short and 
medium chain fatty acids from the inside of the mitochondria (Beiber 1988, Broquist 
1 994). This function ofremoving short-chain fatty acids from the mitochondria may be 
related to the observed increases in acid-soluble acyl carnitine (ASAC), short-chain 
acyl carnitine, in serum and urine of humans and rats during fasting (Frohlich et al 
1978 and Seecombe et al 1978). Free, or non-esterified, camitine (NEC) is decreased 
in serum during fasting and is inversely correlated with both serum free fatty acid and 
,8-hydroxybutyrate concentrations (Frohlich et al 1 978). Increased ASAC, with a 
concomitant decrease in NEC; during fasting, suggests that increased fatty acid 
oxidation may result in a shift in body pools from non-esterified to esterified carnitine. 
The correlation of ASAC and inverse correlation of NEC with serum free fatty acids 
and ,8-hydroxygutyrate suggests that increases in the ratio of ASAC/NEC are 
indicative of an increase in the oxidation of fatty acids. 
Other possible functions of carnitine: 
The concentration of carnitine in the brain is lower than most tissues, but still 
significant (Rebouche 1986). The function of camitine in the brain is unknown since 
the brain is not believed to utilize fatty acids for energy. Recent studies have 
investigated the use of acetylcarnitine for treatment of neurological disorders. In 
streptozotocin induced diabetic rats, treatment with acetylcarnitine was able to reverse 
neurological damage as determined by measurement of nerve conductance velocity 
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(Morabito et al. 1993). In aged rats, acetylcarnitine was able to restore neuromuscular 
conduction velocity to that of young rats after 6 months of treatment (Scarfo et al. 
1992). Human tests with Alzheimer's disease patients have shown some evidence that 
acetylcamitine may ameliorate the symptoms of the disease when given orally (Sano et 
al. 1992). How acetylcamitine may exert the effects reported on neurological function 
is unknown. 
The organ most sensitive to carnitine deficiency is the heart, because the heart relies 
on fatty acids for about 60% of its energy needs (Rebouche 1 986). Primary camitine 
deficiency is a rare syndrome that has been described in children (Pierpont 1992). In 
this disease plasma camitine concentrations are very low resulting in congestive 
cardiomegaly which can be reversed by oral carnitine administration. Cardiomegaly 
can also develop as a result of carnitine being dialyzed out of the blood in hemodialysis 
patients, and camitine should be supplemented in such patients (Kudoh et al. 1983). 
The use of camitine has been investigated for treatment of ischemic heart disease, but 
the results thus far have been contradictory so it is still under investigation (Rebouche 
1 986). 
Camitine has also been shown to reduce the hepatic steatosis seen in chronic 
alcoholic rats (Sachan & Rhew 1 983). Rats fed a diet with 36% of the calories from 
alcohol will accumulate 3-4 times the hepatic lipid content of controls within 8 weeks. 
Rats supplemented with D,L-camitine ( 1  % by weight in the diet or 0.5% L-camitine) 
accumulated less than half the lipids as did the non-supplemented alcoholic rats. The 
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effect of camitine on liver lipids was later shown to be dose dependent with the 
greatest effect at 0.8% D,L-camitine in the diet (Rhew & Sachan 1986). Camitine was 
also shown to reduce the rate of alcohol disappearance from the blood (Sachan & 
Berger 1 993 ). The effect was not seen with choline supplementation although choline 
is very similar in structure to camitine (Sachan & Berger 1993). It was concluded that 
the attenuation of ethanol metabolism was specific for carnitine. The reduced rate of 
ethanol clearance was shown to be the result of reduced ethanol oxidation, even 
though the activity of ethanol oxidizing enzymes was unaffected (Mynatt & Sachan 
1992). 
The hepatic steatosis resulting from aflatoxin B 1 or CC4 administration has also 
been shown to be reduced by camitine supplementation (Sachan et al. 1 993, Sachan 
and Dodson 1 992, Yatim and Sachan 1992). Carnitine also reduced formation of 
aflatoxin adducts with RNA, DNA, and proteins in the liver (Yatim and Sachan 1992). 
Carnitine excretion: 
At normal plasma concentrations, about 90% of the carnitine filtered in the kidney is 
reabsorbed (Engel et al. 1 981 ). The macronutrient content of human diets is known to 
affect both urinary excretion of carnitine and plasma carnitine concentrations. High fat 
diets have been shown to increase both plasma concentration and carnitine clearance 
over low fat diets (Cederblad 1 987). Plasma carnitine concentrations tend to remain 
rather constant at a wide range of dietary intake, and it appears that renal adaptation to 
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carnitine intake is a major regulator of plasma carnitine concentration (Katrib et al. 
1 987). Persons given a diet high in fat, protein, or both excrete significantly increased 
amounts of carnitine (Rebouche et al. 1 993). In that study, the increased carnitine 
excretion appeared to be the result of increased plasma carnitine concentration 
resulting an increased filtered load. Carnitine intakes were constant between groups so 
the diet apparently resulted in increase in either carnitine absorption, biosynthesis, or 
release from tissue stores. 
Camitine-Acyltransferases 
Although carnitine was discovered as a nitrogenous compound of muscle 
tissue in 1905 (Fraenkel, G. and Friedman, S. 1905), it was not until 1 955 that its 
function began to be understood. Fritz ( 1955) demonstrated that carnitine was the 
active component of muscle that was known to increase fatty acid oxidation in liver 
(Lundsgaard, E. 1950). In 1 963 coenzyme A dependent formation of palmitioyl­
carnitine in mitochondria was demonstrated (Bremer, J. 1 962) as well as camitine 
dependent oxidation of palmitoyl-coenzyme A with palmitoyl-carnitine as an 
intermediate (Fritz and Yue 1963). 
As researchers isolated and characterized the carnitine acyl-transferases it became 
clear that there was more than one, based on substrate specificity (Bremer 1983 ). 
Although the issue is not yet resolved, at least three distinct enzymes are known to 
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exist, carnitine-acetyltransferase, camitine-octanoyltransferase, and camitine­
palmitoyltransferase (Broquist 1994). 
Carnitine-acetyltransferase 
Carnitine-acetyltransferase (CAT) catalyzes the transfer of short-chain acyl groups 
from acyl-CoA to camitine to make acylcamitines. The Km of CAT for acetyl-CoA is 
3 7 µM and nearly the same for other acyl-CoAs regardless of chain length. The 
reaction rate, however, in pigeon breast muscle (a common commercial source of 
CAT) is greatest for acetyl-CoA and decreases with increasing chain length of the 
acyl group with decanoyl-CoA having only about 4% of the activity of acetyl-CoA 
(Bremer 1983, Chase 1967, Chase and Tubbs 1966). 
Depending on the species, CAT has a molecular weight ranging from 55,000 - 62 
kDa (Bremer, 1983). Two forms of CAT are found in rat liver, mitochondrial and 
peroxisomal. The two are encoded by the same gene but have divergent sequences at 
the 5' end, the apparent result of alternative splicing mechanism which determines the 
subcellular localization of the gene product (Corti et al. 1 994). 
The functions of CAT are not clearly understood, but the most common function 
attributed to mitochondrial CAT is the regeneration of free CoA by the removal of the 
acyl groups from short-chain acyl CoA in the mitochondrial matrix (Broquist 1994). 
Another possible function is to facilitate the excretion of toxic short chain organic 
acids. Such short chain organic acids may be the result of normal energy metabolism, 
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abnormal energy metabolism (propionic acidemia and methylmalonic acidemia), or 
drug therapy (pivalic acid and valproic acid) and their excretion as carnitine esters, if 
excessive, can result in a secondary carnitine deficiency (Broquist 1994, Rebouche 
1986). 
Carnitine and acetylcarnitine have also been suspected of playing a role in the 
production of the neurotransmitter, acetylcholine, either directly or indirectly as a 
shuttle for acetyl groups from the mitochondria to the cytosol, where acetylcholine is 
formed (McCaman et al. 1 966). Patients suffering with Alzheimer's disease have been 
shown to have decreased CAT activity in the brain (Kalaia and Harik 1992) and 
Alzheimer's patients treated with acetyl-carnitine have been shown to have a reduced 
progression of the disease (Spagnoli et al. 1 991). 
Whether the above roles for carnitine are essential or just facilitory has not been 
clearly established (Broquist 1 994). The presence of CAT in high concentrations in 
muscles such as heart and flight muscles, which rely heavily on fat oxidation for 
energy, may suggest that it is essential for the mitochondrial regeneration of free 
CoA, however. 
Carnitine-octanoyltransferase 
Carnitine-octanoyltransferase (COT) is a 60 kDa protein that has been found in 
the mitochondria, peroxisomes and microsomes of mouse liver (Bremer 1983, 
Broquist 1994). It has a broad substrate range, overlapping with CAT and CPT. The 
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Km of COT for octanoyl-CoA is 15  µM. Octanol-CoA is the best substrate for COT 
with acetyl-CoA and palmitoyl-CoA having reaction rates of 26% and 8 % of that of 
ocatanoyl-CoA (Bremer 1983). The functions of COT are less understood than for 
either CAT or CPT. 
Carnitine-Palmi.toyltransf erases 
There are two distinct CPT enzymes in cells, both of which reversibly catalyze the 
reaction Camitine + Acyl-CoA � Acyl-Camitine + H-S-CoA (Bremer 1 983, 
Hoppel and Tomec 1971 ,  Murthy and Pande 1994 ). One CPT, hereafter referred to 
as CPT-1, is a transmembrane protein located in the outer mitochondrial membrane. 
The other CPT, CPT-11, is bound to the inner surface of the inner mitochondrial 
membrane. Although both enzymes are capable of catalyzing the above reaction in 
both directions, under normal physiological conditions CPT - 1  catalzyes the formation 
of acyl-camitines from acyl-CoA's and CPT-11 the reverse reaction (Figure 2-1). 
CPT activity has also been located in peroxisomes and rnicrosomes of cells 
(Bhuiyan et al. 1 994, Murthy and Pande 1 994) and appear to be distinct proteins from 
the mitochondrial CPT' s. The function of peroxisomal and microsomal CPT has not 
been well characterized. It does not appear that either carnitine or CPT are required 
for the transport of acyl groups into peroxisomes; there is, however, evidence that 
carnitine may be involved in the shuttling of proprionyl-CoA from peroxisomes to 
mitochondria for further oxidation (Jakobs and Wanders 1 995). Because little is 
24 
known about non-mitochondrial CPT, only mitochondrial CPT will be discussed 
further. 
Carnitine Palmitoyltransferase-1 
CPT -1  occurs in at least two isoforms in rats, a liver CPT- 1 ( = 8 8 kDa) and 
skeletal muscle CPT- 1 (=82 kDa) (Britton et al. 1 995). The cDNA for human liver 
CPT-1 has been recently cloned and sequenced and the genomic location determined 
to be on the q (long arm) of chromosome 1 1  (Britton et al . 1995). Mitochondrial 
CPT-I has been proposed to catalyze the rate limiting step in fatty acid oxidation, and 
regulation of its activity to be pivotal in the determination of energy substrate 
utilization (McGarry and Foster 1980). Brady et al. ( 1 993) have suggested, however, 
that mitochondrial CPT- 1 should not be considered rate limiting in fatty acid 
oxidation. They suggest that acyl-camitine formation is actually rate limiting, and that 
acyl-camitines may be the product of microsomal CPT as well as mitochondrial CPT. 
The application of molecular cloning techniques over the last 5 years has clarified two 
long-standing controversies regarding CPT. First, for many years it was debated if 
CPT- 1 and CPT-2 were different proteins or if they were one protein with two 
different catalytic sites. It is now clear that they are two different proteins with 
separate functions and control mechanisms. Second, the issue of how CPT-I and 
CPT-II compare across tissue line·s is partly resolved. It is now known that at least 
two different CPT-1 isotypes exist. L-CPT-1 ,  is found in liver, kidney, and 
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fibroblasts. M-CPT-I, is found in skeletal muscle, adipocytes, and is the predominant 
CPT-I in heart, although heart expresses both types. The two types of CPT-I are 
known to exhibit very different kinetics and inhibition sensitivities. The physiological 
implications of the different regulatory characteristics of CPT -I isotopes are just 
beginning to be understood (McGarry 1995). 
CPT-1 in is known to be regulated in 3 ways. 
1.  By malonyl CoA inhibition (Bremer 1983). 
2. By changes in the sensitivity to malonyl CoA (Cook 1984, Cook et. al . 1984). 
3 .  By changes in the amount of the enzyme present, a result of changes in the rate of 
transcription and translation of the protein ( Chatelain et al. 1996, Mynatt et al . 
1 994). 
The inhibition of CPT -1  by malonyl CoA, the product of the first committed step in 
fatty acids synthesis, represents a negative regulation which insures that fatty acids 
are not being simultaneously synthesized and oxidized (Brady et al 1993). Changes in 
the malonyl CoA inhibition are a short-term regulatory mechanism, while increases in 
the rate of translation and transcription of CPT-1 represent a more sustained 
response, and is typically seen in starvation and diabetes (Brady et al 1993) . An 
unusual property of CPT -1 is that it is also inhibited by high concentrations of 
palmitoyl CoA, of one of its substrates (Bremer 1983, Zierz and Engel 1995). 
CPT-1 has a reported apparent Km for camitine of = 150 µmol/L (Murthy and 
Pande 1992, Kolodziej, M.P., et al . 1992), but shows considerable variation between 
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species and tissues with reported values as low as 32 µmoVL for rat liver but 507 
µmoVL in muscle from the same animals, and 695 µmoVL for dog heart (McGarry et 
al. 1 983) . The reported apparent Km ofCPT-1 for palmitoyl-CoA is considerably 
more uniform, at least in rat tissues, with 30 and 60 µmoVL being reported for rat 
liver and skeletal muscle respectively (McGarry et al 1983). 
Although CPT-1 in all tissues appears to be inhibited by malonyl CoA, there 
appears to be two distinct isotypes with different sensitivities to malonyl CoA. The 
CPT-1 of liver and kidney are one type whereas that of skeletal muscle and adipose 
tissue are a slightly smaller protein which is much more sensitive to malonyl CoA 
(Brady et al . 1 993, Esserson et al. 1 996, Saggerson et al . 1981, ). Rat heart contains 
both liver and muscle CPT-1 (Brown et al. 1995). In neonatal rats the liver isoform 
contributes about 25% the total CPT-1 activity, but decreases with age to about 4% 
in adult animals. 
Carnitine-Palmitoyltransferase-11 
CPT-II occurs as only one isotype in all tissues and is =68-kDa in size (Brady et 
al 1993). As previously mentioned, CPT-11 can catalyze bi-directionally. The CPT-11 
Km for carnitine, however, is about 1 0  times higher than for CPT-I (1 .5 mmol/L) 
assuring that the reaction will always predominate in the reverse direction under 
physiological conditions (Brady et al 1993). Unlike CPT-I, CPT-II is not inhibited by 
malonyl CoA, and all changes in activity appear to associated with corresponding 
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changes in the amount of protein present as well as the level of expression of its 
mRNA as determined by northern blots, and nuclear transcription rates as determined 
by nuclear run-on assays (Brady et al 1 993). The human chromosomal CPT-II gene 
has not been yet been cloned ( cDNA for the gene has been cloned) but it has been 
localized to the p32 region of chromosome 1 (Britton et al. 1 995). 
Interactions Between Nutrients 
The concept of a nutrient interacting with another nutrient in ways that affect the 
tissue concentrations or dietary requirement for that nutrient is not new. It was 
reported in 1 94 7 that dietary tryptophan reduces the dietary requirement for niacin 
(Krehl 1 947, Young & Fukagawa 1 988). 
Interaction between vitamin C and iron: 
A classical nutrient-nutrient interaction is that between vitamin C and iron. 
Vitamin C is able to increase the absorption of iron by keeping it in the reduced (F e2+) 
state, and by chelating it and keeping the iron in a more soluble form (Hallberg 1981). 
Vitamin C is also important in other aspects of iron metabolism such as synthesis of 
hemoglobin and the removal of iron from ferritin (Hallberg 1 98 1  ) .  
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Interaction between calcium and magnesium: 
Similar nutrients often affect each other, such is the case with the two divalent 
cations calcium and magnesium. It has been reported that increasing the calcium 
consumption in humans can reduce absorption of dietary magnesium (Kim & 
Linkswiler 1980). In rats fed a parenteral nutrition diet with graded doses of calcium, 
urinary excretion of magnesium increased as calcium supplementation increased (Al­
Jurf & Chapman-Furr 1 985). Calcium, therefore, may decrease absorption and 
increase excretion of magnesium simultaneously. 
Interaction between choline and carnitine: 
Choline and carnitine are also very similar in structure as shown here. 
(CH3)3-N-CHi-CH-CH2-COOH 
I 
OH 
Carnitine Choline 
With such striking similarity, it would not be surprising if interactions were found. 
Rats that are fed a choline deficient diet have been shown to have reduced carnitine 
concentrations in liver, heart, and skeletal muscle, but increased plasma carnitine 
concentrations compared to animals fed a choline supplemented diet (Carter & Frenkel 
1 978). Comparisons were not made to a control diet in this study. 
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Choline deficiency results in a decrease in lipid oxidation in heart and liver cells 
that can be reversed in vitro by the addition of carnitine (Corredor et al. 1967). The 
difference in carnitine levels in this study were even more dramatic after the animals 
were fasted for 48 h. Carnitine concentrations increased almost four fold in liver and 
significantly in heart and muscle after fasting of the choline supplemented animals. In 
the choline deficient animals camitine increased in the liver about 3 fold but decreased 
only slightly in heart and muscle. It would appear that increases in carnitine 
concentrations are a part of the adaptation to fasting that is impaired when there is 
choline deficiency in rats. 
It was shown in another study that the decreased hepatic carnitine in choline 
deficient rats results in a four fold decrease in oxidation of 14C palmitate and an 
increased incorporation into triglyceride in liver homogenates ( Corredor et al. 1967). 
Addition of carnitine, but not choline, in the liver homogenates restored palmitate 
oxidation to control levels and decreased the rate of esterification of palmitate to 
glycerol. This suggested that the fatty liver seen in choline deficient rats may be due in 
part to a lack of carnitine. 
Two enzymes, choline-acetyltransferase and carnitine-acetyltransf erase, also 
exhibit similarities, catalyzing the transfer of acetate from acetylcoenzyme A to 
choline and carnitine respectively. Carnitine-acetyltransferase has weak choline 
acetyltransferase activity, but choline-acetyltransferase is not cross reactive (Sastry & 
Janson 1994). 
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Choline and pantothenic acid supplementation has also been shown to reduce 
carnitine concentrations in plasma and 24 hr urine of humans (Mynatt et al. 1 988, 
Dodson & Sachan, 1992). Follow-up studies demonstrated that the effect on carnitine 
was due to choline and not pantothenic acid (Sachan et al. 1 993, Dodson and Sachan 
1996). The results of these studies raised a number of intriguing questions which could 
not be adequately answered by reasonable experiments in humans. The questions 
included 1) Are the decreases in plasma and urine carnitine concentrations a reflection 
of choline-induced carnitine deficiency or an altered partitioning of carnitine among 
tissues? 2) Is choline effect mediated via the carnitine transporters in tissues? 3) What 
are the consequences of the decreased carnitine concentrations in plasma and urine? 
A need for an animal model was clearly realized and a series of studies was 
initiated for the purpose of finding a good animal model to study the choline-carnitine 
interactions. An animal model was established, and is discussed in the next chapter. 
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Chapter 3 
Preliminary Research and Objectives 
The observation that choline and pantothenic acid supplementation resulted in a 
decrease in camitine excretion to less than half that of unsupplemented subjects raised 
several interesting questions. First, was this a supplement induced carnitine deficiency, 
and if so which supplement? Some individuals had normal or higher plasma carnitine 
concentrations while others had lower concentrations, plasma data were inconsistent 
(Dodson and Sachan 1996). Supplemental camitine, in both control subjects and 
those supplemented choline and pantothenic acid, increased urinary carnitine 
excretion above baseline values. However, carnitine excretion in the choline and 
pantothenic acid supplemented subjects was still about half that of controls. 
There was no way of knowing how body carnitine pools other than urine and 
plasma were being affected, therefore an animal model was needed to study what 
effect choline was having on tissue concentrations and the total body pool of 
carnitine. 
Rats were first used as an experimental model to study the interaction of choline 
and pantothenic acid on carnitine in humans. There was no effect of either choline, 
pantothenic acid, or both combined on either urinary excretion or plasma 
concentration of carnitine in rats (Daily and Sachan 1995). It was postulated that the 
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lack of effect in rats might be due to their high liver choline oxidase activity (Table 3-
1 ). The animal with the choline oxidase activity nearest that of humans is the guinea 
pig. Guinea pigs were less convenient because of difficulty in drawing blood, but 
would hopefully respond similarly to humans when supplemented with choline. 
Table 3-1 
Liver Choline Oxidase in Selected Species 
Species 
Rat 
Chicken 
Mouse 
Hamster 
Monkey 
Guinea Pig 
Human 
Choline Oxidase Activity 
2408 ± 12 1  
1 3 1 1  ± 8 
895 ± 72 
361 ± 63 
144 ± 21  
1 36  ± 43 
40 ± 7 
1Taken from Sidransky and Farber ( 1 960). Activity units are in microliters of 02 
uptake/brig wet liver ± SEM. 
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Pantothenic acid had no effect on either urinary excretion or plasma concentration 
of carnitine in guinea pigs (Daily and Sachan 1993). Choline supplementation (3g/kg 
diet), however, resulted in a significantly lowered carnitine excretion, similar to that 
seen in humans (Table 3-2). Plasma concentrations of carnitine were significantly 
higher in the choline supplemented group than in the non-supplemented group at the 
end of the study. This was different than what was seen in humans. Human studies had 
shown a trend toward a decrease in plasma carnitine concentrations with choline 
supplementation (Mynatt et al. 1988). A subsequent human study has clearly 
demonstrated, however, that choline affects human plasma carnitine concentrations 
differently for different individuals, some increasing and some decreasing (Dodson and 
Sachan 1996). 
The decreased excretion of carnitine in humans and guinea pigs had several 
possible explanations. Since there was no consistent change in plasma concentrations 
of carnitine in humans, the decreased excretion would suggest a conservation of 
carnitine, or a decrease in available carnitine. One possibility was that absorption of 
dietary carnitine was impaired by choline supplementation. However, the camitine 
content of the guinea pig diet was so low that it was not detectable, therefore, 
impaired absorption would have no significant affect on the guinea pigs if that were 
the cause. 
Another possibility was that carnitine synthesis was impaired. However, it has 
never been shown that carnitine synthesis is impaired by choline. In fact, 
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Table 3-2 
Effect of Choline Supplementation on Urinary Excretion 
and Plasma Concentration of Carnitine in Guinea Pigs1 
Level of Choline 
Supplement 
Camitine 
(g/kg diet) 
0 
3 
0 
3 
0 
3 
0 
3 
NEC ASAC AIAC 
Day O of Study, Urinary Excretion (µmoVd) 
1.3 ± 0.2 
1.5 ± 0.2 
0.9 ± 0.2 
0.8 ± 0.2 
0.1 ± 0.01 
0.1 ± 0.03 
Day 5 of Study, Urinary Excretion (µmoVd) 
1.5 ± 0.2 
0.4 ± 0.1 * 
0.6 ± 0.1 
0.3 ± 0.0* 
0.1 ± 0.01 
0.1 ± 0.01 
Day IO  of Study, Urinary Excretion (µmoVd) 
1.7 ± 0.1 
0.5 ± 0.1* 
0.8 ± 0.2 
0.5 ± 0.1 
0.1 ± 0.01 
0.1 ± 0.01 
TOTAL2 
2.2 ± 0.3 
2.4 ± 0.3 
2.6 ± 0.4 
0.8 ± 0.1* 
2. 5 ± 0.3 
1.1 ± 0.1 * 
Day IO of Study, Plasma Concentration (µmoVL) 
38.1 ± 2. 1 
47.2 ± 1.8* 
16. 1 ± 4.3 
30.8 ± 6.0 
I . I  ± 0.2 
0.9 ± 0.1 
54.4 ± 4.5 
74.0  ± 5.9* 
1 Values are means ± SEM for the groups. Guinea pigs were fed grount diet with 
either no supplement or 3 g/kg choline from choline chloride for 10 days ( diet 
contained l .85g/kg choline without added supplement). On d O (pre-experimental 
diet) and d 5, n = 12 for both groups; on day 10, n = 6 for the choline supplemented 
group and n = 6 for the non-supplemented group. 
An asterisk indicates significant difference between the supplemented and non­
supplemented groups (P ::; 0.05) by Student's t test. 
2NEC = non-esterified camitine, ASAC = acid-soluble acyl carnitine, AIAC = acid­
insoluble acyl carnitine, Total = total carnitine (Daily and Sachan 1995). 
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just the opposite occurs in rats, choline deficiency impairs carnitine synthesis (Carter & 
Frenkel 1 978). Comparing carnitine biosynthesis between groups in a definitive 
manner is not possible. Frequently, rates of synthesis can be compared by comparing 
the activity of biosynthetic enzymes. Carnitine biosynthesis, however, does not appear 
to be enzymatically regulated. Rather, it appears to be regulated by release of 
trimethyllysine as proteins are broken down (Sandor & Hoppel 1 989, Sandor 1990). If 
decreased carnitine biosynthesis is responsible for the decreased excretion of carnitine 
in choline supplemented humans and guinea pigs, that might be reflected in decreased 
tissue concentrations of carnitine. 
To explore that possibility, another group of guinea pigs was studied for the 
purpose of obtaining more tissue samples. Blood collections were taken during the 
course of this study, instead of just at the end. Urinary excretion of free and total 
carnitines were reduced in the choline supplemented group as before, but acyl 
carnitines were elevated in both groups but more so in the choline supplemented group 
(Daily and Sachan 1995). No tissue carnitine concentrations were lower in the choline 
supplemented group, and the camitine concentration was significantly higher in 
skeletal muscle (Figure 3-1 ). This demonstrated conclusively that there was not a 
choline-induced carnitine deficiency in guinea pigs. 
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Figure 3-1: Effect of choline supplementation on tissue concentrations of total 
carnitine in guinea pigs. Each group was fed guinea pig diet either supplemented 
(ChS group) with choline (3g/kg diet) or with no supplement (NS group). Values 
are group means ± SEM (n = 12) . Significant difference between groups by 
Student' s  t test is indicated by an asterisk (Daily & Sachan, 1 995). 
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· Plasma �-hydroxybutyrate was also higher in the choline supplemented guinea 
pigs (Daily & Sachan 1 995). This raised two questions. First, were the serial blood 
collections (by cardiocentesis) under anesthesia responsible for the increase in acyl 
camitine and �-hydroxybutyrate? This was later confirmed in a study of the effect of 
anesthesia and cardiocentesis on urinary excretion (Park et al. 1995, Park et al. 1996). 
Second, if the anesthesia and blood collection were responsible, did the higher plasma 
�-hydroxybutyrate and urinary acyl-carnitine indicate that choline supplemented 
guinea pigs have an increased capacity for fatty acid oxidation? 
Only one dose of camitine in humans (20mg/kg body weight) and another in 
guinea pigs (3 g/kg diet) had been used in these studies. The human dose was based on 
the amount used by the individual in which the choline effect was first observed 
(Dodson and Sachan 1996, Mynatt et al. 1 988). The dose used in guinea pigs 
represented a similar percent increase over normal dietary choline as was shown to be 
effective in humans, thereby demonstrating a similar effect with similar increases in 
choline intake. What level of choline supplementation is required to be effective, and 
how much is required for a maximal effect, remained unanswered. 
The following studies were designed to address : 1) the possible functional 
consequences of this newly discovered choline-camitine interaction on fatty acid 
oxidation in guinea pigs, and 2) the minimal choline dose required to obtain the effect 
on carnitine status, and the dose which yields the maximal effect. 
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Chapter 4 
Effect of Varied Choline Doses on Plasma, Urinary 
and Tissue Carnitine in Guinea Pigs 
Introduction 
Choline and carnitine are two trimethylated quaternary amines that are very 
similar in structure, but without many similarities in function. Both use different 
transport proteins for intestinal and renal absorption. Both can be acetylated by 
similar CoA-dependent acetyl-transferase enzymes, but for different purposes. In the 
past, studies of choline-carnitine interactions have evaluated the effect of choline 
deficiency on carnitine status (Aarsaether et al 1988, Carter and Frenkel 1 978, 
Corredor et al 1967). These studies have demonstrated that choline deficiency in rats 
result in a decrease in liver, heart and skeletal muscle carnitine, and that fatty acid 
oxidation is impaired. We, however, have demonstrated an effect of choline 
supplementation in excess of normal dietary intake on carnitine homeostasis (Daily 
and Sachan 1 995, Dodson and Sachan 1996). Choline supplementation in humans 
(20 mg/kg body weight) and guinea pigs (3 g/kg diet) results in a decrease in urinary 
excretion of carnitine to less than half normal values. In these studies, plasma carnitine 
concentrations were variably affected in humans, but were increased in guinea pigs. 
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Tissue concentrations of camitine were also affected in guinea pigs, with choline 
supplementation causing a significant increase in skeletal muscle camitine; however, 
tissue carnitine concentrations have not yet been determined in humans. 
The choline dose in the above human study was based on what was observed in a 
person using a choline supplement in which the effect on carnitine was first observed 
(Dodson and Sachan, 1 996). The levels of choline supplementation in guinea pigs 
reflected a similar increase over normal dietary choline levels ( the level of supplement 
was approximately 1 .  7 times that found in the diet). In neither species, however, has 
either a minimal effective choline dose or the level of choline supplementation for 
maximum effect been determined. The primary objective of this study was to 
determine such dose effects in guinea pigs. 
Low carnitine excretion in humans is frequently the result of a low dietary intake 
of carnitine. Low dietary intake of carnitine in choline supplemented guinea pigs can 
not be the reason for reduced excretion of carnitine because the guinea pig diet is 
essentially carnitine free (Daily and Sachan 1995). It is possible that if carnitine were 
being lost from the intestinal tissue, excreted into the intestinal lumen, and then not 
reabsorbed, that a reduced urinary carnitine excretion could be a compensatory 
mechanism to preserve camitine. An intestinal loss into the lumen would be expected 
to result in a decrease in gut tissue camitine with a simultaneous increase in camitine 
in the lumen contents, and possibly fecal carnitine. Therefore, a secondary objective 
was to evaluate the likelihood of intestinal loss of camitine by determining its 
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concentrations in intestinal tissue, lumen contents, and feces. Additional secondary 
objectives of these studies were to I) determine the effect of choline on total body 
carnitine, 2) determine the effect of choline on body composition, and 3) determine 
the effect of choline on feed efficiency in guinea pigs. 
Materials and Methods 
All research protocol for these studies were approved by the Animal Care and Use 
Committee of the University of Tennessee. Prior to the dose response study an attempt 
was made to use a semi-purified diet for the dose response study. Ten male, nine week 
old, Hartley guinea pigs (SASCO, Inc; Omaha, NE) were divided into two groups of 
five and fed either ground commercial guinea pig diet (Purina Guinea Pig Chow no. 
5025, Purina Mills, Richmond, IN) or a semi-purified diet (Table 4-1). With one 
exception, the guinea pigs did not eat the semi-purified diet, and the one that did eat, 
consumed less than the animals on the control diet (Table 4-2) . The self-induced 
starvation resulted in an average weight loss of almost 40 grams in 5 days, during the 
same period the animals on the commercial diet gained an average of about 30 grams. 
For one day, the semi-purified diet was supplemented with 4% alfalfa flour, but this 
resulted in only a small change in acceptance of the semi-purified diet by one animal 
(Table 4-2). It was decided that the guinea pigs would not eat a semi-purified diet 
normally, and that using a choline supplemented commercial diet, as used in previous 
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Table 4-1 
Composition of Guinea Pig Semi-Purified Diet 
Ingredient g/kg Diet 
Soy Protein 200.00 
L-Arginine 3 .00 
D,L-Methionine 5.00 
Com Oil 50.00 
Com Starch 1 50.00 
Sucrose 140.00 
Glucose 120.00 
Mineral Mix 67.50 
AIN Vitamin Mix 10.00 
Ascorbate 1 .00 
Choline Chloride 2.47 
Alphacel 25 1 .03 
42 
Table 4-2 
Food Consumption and Weight Gain or Loss in Guinea Pigs 
Fed Ground Commercial Diet or Semi-Purified Diet1 
Groups 
Commercial Diet Semi-Purified Diet 
Feed Consumption (g/d) 
Prior to Experimental Diets 
Feed Consumption (g/d) 
While on Experimental Diets 
30.80 ± 1 . 1 0 
3 1 .24 ± 1 .61  
Feed Consumption (g/d) While on Semi-Purified 
Diets With 4% Alfalfa Added 
Weight Change (grams) 
During Experimental Period + 29.6 ± 7.22 
30.90 ± 0.84 
5 . 56 ± 1 . 80 
8.00 ± 4.59 
- 39.4 ± 12 .77 
1Values shown are the means for the group over 5 days ± SEM. 
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studies, would be more satisfactory. Because this was a dose response study, it would 
be undesirable for daily choline intake to be determined by the willingness of animals 
to eat normally rather than the choline concentration of the diet. Other researchers 
have also experienced difficulty in getting guinea pigs to eat semi-purified diets. For 
example, Teo et. al. ( 1991 )  reported that weanling male Hartley guinea pigs had to be 
selected for their adaptability to a semi-purified diet . 
Of the ten guinea pigs, 2 were transferred to another study and the 8 remaining 
were divided into four groups of two and used for the first of two trials in the dose 
response study. After completing the study with the first 8 guinea pigs, 12 additional 
male Hartley guinea pigs ( 5 week old) were purchased and divided into 4 groups of 3 
to complete the study with a total of 20 guinea pigs. All animals were individually 
housed in stainless steel wire mesh cages except when urine was being collected. All 
animals were allowed free access to water and feed ( Purina Guinea Pig Chow no. 
5025, Purina Mills, Richmond, IN) for one week prior to the beginning of the study, 
and to water and their respective diets during the study 
There were four groups of five guinea pigs assigned to one of the four doses of 
dietary choline supplement. Experimental diets were prepared by grinding guinea pig 
diet and adding either no choline or 2, 5, or 1 0  g choline from choline chloride per kg 
diet (Table 4-3). Since the diet contains endogenous choline of approximately 1 . 85 
g/kg diet, this represents a range from approximately 2 - 12 g/kg diet. 
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Table 4-3 
Choline Content of Control and Experimental Guinea Pig Diets 
Experimental Groups 
NS 2ChS 5ChS lOChS 
Choline from Diet (g/kg) 1 .85 1 .85 1 .85 1 .85 
Choline Added to Diet (g/kg) 0.00 2.00 5.00 10.00 
Total Choline in Diet (g/kg) 1 . 85 3 .85 6.85 1 1 .85 
The first set of guinea pigs included those that had been on the semi-purified diets 
and began the study after the group on semi-purified diets regained their weight and 
were comparable in weight with the guinea pigs fed the commercial diet. The second 
set of guinea pigs was placed on experimental diets one week after arrival. 
Throughout the study, records were kept of food consumption and weight gain. 
Feed efficiency was calculated as the amount of weight gained in grams per gram of 
feed eaten (g weight gain/g feed eaten). Urine was collected before beginning the 
experimental diets and on days 2, 5, 1 4, and 2 1  and feces collected on day 2 1  of the 
dietary treatment. Urine was collected by placing the animals in acrylic metabolic 
cages for 24 hours with a urine collector containing 1 ml of O .2 mol/L HCI. Blood was 
collected by cardiac puncture under open drop methoxyflurane anesthesia on day 2 1 .  
The blood was centrifuged and the plasma frozen at -20°C until assayed. Following the 
blood collection, the guinea pigs were killed by decapitation while still under 
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anesthesia. The small intestine was clamped at the ilea! and duodenal ends, surgically 
removed and the lumen contents flushed twice with 10  ml of saline and the flush saved 
for carnitine assay. The intestine was then divided into 3 segments and each segment 
measured, weighed, and frozen at -80°C until assayed for carnitine. Heart, brain, 
kidneys, liver, and gastrocnemius muscle were also removed, and stored at -80°C for 
carnitine assay. Animal carcasses were saved and frozen at -80°C for proximate 
analysis and total body carnitine determination. 
Carniti.ne Assay: 
Carnitine was assayed in blood, urine, and tissue samples by a modified 
radioisotopic method of Cederblad and Linstedt (Cederblad and Lindstedt 1972, 
Sachan et al. 1984). In this assay, acid insoluble long-chain acyl carnitines (AIAC) are 
precipitated using perchloric acid, leaving the short-chain acid soluble acyl carnitines 
(ASAC) and the non-esterified camitines (NEC) in the supernatant. An aliquot of the 
supernatant is assayed to determine the NEC concentration and another hydrolyzed 
with 0. 5 N KOH to assay all acid soluble carnitines. ASAC is the difference between 
the total acid soluble carnitines and the NEC. The pellets are drained, washed, 
suspended in 0.5 N KOH, and hydrolyzed in a water bath at 60°C for 60 minutes and 
assayed for carnitine. 
In each case carnitine is determined by using carnitine acetyl transferase (Sigma 
Chemical Co., St Louis, MO) to esterify carnitine to a 14C-acetate from 1 ,  14C-acetyl 
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CoA (Moravek Biochemicals, Brea, CA). Unreacted 14C-acetyl CoA is removed from 
the reaction mixture by running the reaction mixture through anion exchange columns 
and the radioactivity of samples and standards determined using a Beckman LS3801 
liquid scintillation counter. 
Total body camitine was estimated by determining camitine in liquid carcass 
homogenates, and adding to that amount the amount of carnitine removed with 
organs and tissues. Organ and tissue camitine was determined by multiplying the 
camitine concentration by the weight of the tissue. This method probably resulted in 
a small underestimate of total body camitine since the large intestine, stomach, and 
caecum were removed but not assayed for camitine. 
Creatinine and Renal Function: 
Creatinine assays in urine were performed by the Jaffe reaction according to the 
methods ofTaussky ( 1954) as modified by Henry ( 1967). Plasma creatinine was 
determined using another modification of the Jaffe reaction by Raffael (1 976). 
Creatinine clearance was calculated from plasma concentration and 24h urinary 
excretion of creatinine, using the equation : Clearance = (UxfPx)V where 
Ux = 24 h urinary creatinine excretion, P x = plasma creatinine concentration, and V = 
urine flow in ml per minute. Camitine clearance was calculated by the same equation 
except Ux and P x = are 24 h urinary carnitine excretion and plasma camitine 
concentration, respectively. 
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Fractional tubular reabsorption (FTR) of camitine was calculated by the formula 
(Zamora et al. 1995) : 
FTR% = {l _ 
Ucne x Pcreat} x 1 00 
Pcne Ucreat 
Where FTR = fractional tubular reabsorption, Ucne = 24 h urinary excretion of 
camitine (µmol/d), Pcne = plasma concentration of carnitine (µmol/L ), Pcreat = 
plasma concentration of creatinine (µmol/L ), and Ucreat = 24 h urinary excretion of 
creatinine (µmol/d). 
Proximate analysis of Guinea Pig Carcasses 
Guinea pig carcasses were thawed and shaven to remove hair. Large intestines, 
stomach, and caecum were removed. The carcasses were homogenized in a blender 
and the homogenate lyophilized for moisture determination. Aliquots of the dried 
homogenate were assayed for protein by the kjeldahl method (Official Methods of 
Analysis 1 984). Percent fat was determined by soxhlet extraction for 12 h using 
hexane as the solvent. The percent fat in the sample was determined both by the 
amount of the fat recovered in the flask, and by the loss of weight from the sample, 
after extraction. The values obtained from the two methods were averaged for the 
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reported fat percent. Mineral ash percent was determined by ashing an aliquot of the 
lyophilized sample in a muffle furnace at 650° C. 
Statistics 
All values are expressed as group means ± SEM. Urinary camitine excretion was 
expressed as µmol carnitine excreted per mmol creatinine. Significance of differences 
were determined using analysis of variance (ANOV A) and Tukey' s test. Statmost for 
Windows version 2.01 (DataMost Corp., Salt Lake City, UT) was used for ANOV A. 
For uniary excretion of camitine differences were evaluated using a repeated 
measures ANOVA using the l\fiXED procedure of SAS (Cary, N.C.) .  When the F 
test indicated differences between groups, the differences were separated using 
Fisher' s protected least significant difference test . For regression analysis the 
regression curve was generated using Excel for Windows version 5 .  0 and regression 
analysis performed using SAS (Cary, NC). 
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Results 
The difference in the ages of the two sets of guinea pigs introduced enough 
variation in body weights, food consumption, and weight gain so that these data from 
the two sets could not be meaningfully combined for analysis. There were no 
significant differences among the dietary groups in initial and body weight, weight 
gain, feed consumption, or feed efficiency in either set of animals (Table 4-4). 
Urinary excretion of carnitine was significantly lower in all three groups of 
choline supplemented guinea pigs than in the nonsupplemented group on day 5 and 
for the remainder of the study (Table 4-5). There was a time dependent increase in 
urinary carnitine excretion in the nonsupplemented group, that was not seen in the 
supplemented groups. There was no apparent dose effect during that period since the 
different levels of choline supplementation did not result in significantly different 
urinary excretions of carnitine. On day 2, the excretion of the carnitine in the animals 
supplemented with 5 and 1 0  g choline per kg diet was approximately half that of the 
unsupplemented animals, although this difference was not statistically significant. 
Carnitine concentration was determined in plasma, kidney, brain, liver, heart, and 
skeletal muscle (Table 4-6). Plasma, brain, and liver concentrations of carnitine were 
not significantly different between any of the groups. Kidney free carnitine was higher 
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Table 4-4 
Feed Consumption, Weight Gain, and Feed Efficiency in 
Choline Supplemented and Non-Supplemented Guinea Pigs1 
Level of Choline 0 
Supplement (g/kg diet) 
First Set of Guinea Pigs 
Beginning Weight 926.0 
Final Weight 930.5 
Weight Gain 4.5 
Feed Eaten 938.0 
Feed Efficiency 0.0068 
Second Set of Guinea Pigs 
Beginning Weight 300.7 ± 20.5 
Final Weight 402.7 ± 35 .4 
Weight Gain 102.0 ± 17.0 
Feed Eaten 5 13 .0 ± 3 1 . 5 
Feed Efficiency 0. 1962 ± 0.02 1  
2 5 IO  
888.0 914.5 895 .5  
9 14.0 9 14.5 9 14.5 
26.0 0.0 19.0 
838.5 939.0 856.0 
0.0339 0.0002 0.0248 
302.7 ± 3 .8 3 14.3 ± 1 1 .6 298.3 ± 17.0 
42 1 .7 ± 9.7 43 1 .7 ± 9.6 405.3 ± 1 5.3 
1 1 9.0 ± 9.0 1 17.3 ± 14.4 107.0 ± 4.2 
556.3 ± 25.3 573 .7 ± 39.3 500.0 ± 24.9 
0.2 134 ± 0.007 0.203 1 ± 0.0 1 1 0.2 148 ± 0.0 1 1 
1Values are group means (± SEM for the second set of guinea pigs) (n = 2 for the first 
set and n = 3 for the second set). Differences between groups were evaluated by 
ANOV A test but differences were not significant (P < 0.05). 
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Table 4-5 
Urinary Excretion of Carnitine in Guinea Pigs Supplemented 
With Varied Levels of Choline for 21 Days1 
Level of Choline 
Supplement 
NEC 
(g/kg diet) 
0 14 .o· 
2 12.6 
5 19.9 
10 21.9· 
0 32.2a,t 
2 27.4ab 
5 11.4b 
10 14.6b,•t 
0 31.4a, t 
2 14. 1 ab 
5 7.6bc 
10 5.9c.t 
Camitine (µmol/mmol Creatinine) 
ASAC AIAC TOTAL2 
Day O of Study 
8.5 0.1· 23 .2· 
9.8 0.4· 22.8 
11.0 0.4· 3 1 .4 
11.8 0.6·ti 34_3• 
Day 2 of Study 
12.5  0.9· 45_5t 
14.7 o.8· 42.7 
10.4 0.3· 22.0 
15.5 o.3•t 30.4•t 
Day 5 of Study 
16.5 0.4· 48.3a,t 
9.8 0 .3·  24.2b 
7.6 0.2· 15.4b 
5.8 0.2· 12.3b,t 
Continued 
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Level of Choline 
Supplement 
NEC 
(g/kg diet) 
0 52.7a, t 
2 12.4b 
5 20.4b 
10 16.3b,*t 
0 40.5a, tt 
2 18.7b 
5 18.4b 
10  9_9b,•t 
Pooled 
Standard Error 6.5 
Table 4-5 Continued 
Carnitine (µmolimmol Creatinine) 
ASAC AIAC TOTAL 
Day 14 of Study 
18.6 3 .2a,t 74_ga.t 10.2 1 _5b,t 24 . l b 
14 .7 1.5b,t 37.7b 
16.5 1 .2: 36.5b,• 
Day 2 1  of Study 
17.8 2.8a.t 6 1 . l a,ti 
11.8 l .3b,t 3 1 . 7b 
1 1 .4 1.6b,t 31.4b 
7.8 I .ob.ti 18.6b,•t 
..., ..., 0.3 8.5 ., ·"' 
1Values are means for the group, pooled standard error for carnitine fractions are 
shown at the bottom of the table. Values in a column, for each day of the study, with 
a different letter superscript (a,b,c) are significantly different from others in the same 
column at the same time period (P < 0.05, n = 5). Differences over time within 
supplement groups, for each column, are indicated by different symbol superscripts 
(*, t,t), (P < 0.05, n = 5). 
2NEC = non-esterified carnitine, ASAC = acid-soluble acyl carnitine, AIAC = acid­
insoluble acyl carnitine, Total = total camitine. 
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Table 4-6 
Plasma and Tissue Concentrations of Carnitine in Guinea Pigs 
Supplemented With Varied Levels of Choline for 21 Days1 
Level of Choline 
Supplement 
NEC 
(g/kg diet) 
0 33 .1  ± 6 .0 
2 40.4 ± 4.0 
5 36.6 ± 8.3 
10  15.6 ± 2.1 
0 131.7 ± 24.2 
2 21 1 .3 ± 54.5 
5 154.1 ± 9.7 
10  208.1 ± 51 .4 
0 326.3 ± 48.9 
2 341 .0 ± 34.4 
5 359.0 ± 32.9 
10  357.0 ± 43.4 
Carnitine 
ASAC AIAC TOTAL 
Plasma (µmol/L) 
2.6 ± 1 .2 2.2 ± 0.7 37.9 ± 6.6 
9.1 ± 3.4 2.9 ± 0.6 52.3 ± 4.5 
8.9 ± 2.5 1 .3 ± 0.5 46.8 ± 11 .2 
25.2 ± 7.3 2.0 ± 0.6 42.8 ± 6.3 
Brain (nmol/g) 
31 .0 ± 145.0 43.1 ± 7.6 205.8 ± 44.3 
39.3 ± 16.4 41 .2 ± 4.8 291.8 ± 70.0 
26.5 ± 6.6 34.5 ± 2 .7  215.1 ± 12.1 
26.0 ± 9.9 46.2 ± 9.9 280.3 ± 63.7 
Liver (nmol/g) 
5.3 ± 5.3 12.5 ± 1 .1 344.1 ± 50.5 
12.8 ± 5.3 1 1 .3 ± 2.5 365.1 ± 38.9 
21.8 ± 1 0.3  8.6 ± 2.0 389.4 ± 42.8 
1 7.9 ± 1 0.6 1 3.2 ± 3.8 388.2 ± 62.6 
Continued 
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Level of Choline 
Supplement 
NEC 
(g/kg diet) 
0 379.8 + 19.5a 
2 397.1 + 18.4ab 
5 391 . 5 + 24.3ab 
10  428. 1 ± 19.3b 
0 1042.5 + 145.9a 
2 1311.2 + I 08.2ab 
5 1373 .0 ± 14 I .8bc 
10  1063.0 ± 90. 5a 
0 544.9 ± 25 .0 
2 635.0 ± 39.7 
5 608.9 ± 56.9 
10  624.1 ± 1 18.6 
Table 4-6 - Continued 
Camitine 
ASAC AIAC 
Kidney (nmol/g) 
55 .6 ± 13.9 1 5 .4 + 2.5a 
59.6 ± 7.0 17.3 + 0.9ab 
68.6 ± 22.4 21 .0 + I . Sb 
39.0 ± 6.5 1 8.7  ± I . l ab 
Heart (nmol/g) 
479.6 ± 33 .1  
505 .5  ± 67.1 
479.6 ± 61 .2 
395 .4 ± 72.0 
23.2 ± 12 .7a 
50.8 ± 8.3ab 
88.4 + 7.9b -
b 87.2 ± 29.8 
Skeletal Muscle (nmol/g) 
48.7  ± 14.7a 21 7.3 ± 27.9 
96.2 ± 33 .4a 251 . 8  ± 42.4 
1 03.0 + 16. 1  a 230. 1 ± 18.6 
19 1 .2 ± 29.9b 23 1 .0 ± 64.7 
TOTAL 
450.8 ± 18.6 
474.0 ± 19.0 
481 .1 ± 21 .2 
485 .7 ± 21 .6 
1 545 .2  + 140. 7• 
1867.4 + 130.5b 
1941 . 0 ± 15  3 .  1 b 
1 545.6 ± 28.2· 
810.9 + 27.6a 
983 .0 + 51 .6b 
942.2 + 65.5ab 
1 046.3-± 117.3b 
1Tissue concentrations are nmol/g wet tissue. Values are expressed as means for the 
group (n=5) ± SEM. Values in a column with a different superscript are significantly 
different (P < 0.05) by ANOVA and Tukey's test. 
2NEC = non-esterified camitine, ASAC = acid-soluble acyl camitine, AIAC = acid­
insoluble acyl camitine, Total = total carnitine. 
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in the group supplemented with 1 0  g choline per kg diet, but there was no significant 
trend in the other fractions or in total camitine. In the heart muscle, the AIAC was 
elevated in all choli�e supplemented animals. In the groups supplemented with 2 and 
10  g choline per kg diet, both free and total camitine were significantly higher than in 
the nonsupplemented animals. There were no differences in heart ASAC between 
groups. Heart camitine concentrations were not different for any fractions except 
AIAC or for total camitine in the group supplemented with 10  g choline per kg diet. 
All choline supplemented groups of guinea pigs had higher total camitine 
concentrations in skeletal muscle. Although there appeared to be a dose dependent 
increase in ASAC in muscle of choline supplemented animals, differences were 
significant only in the IO  g choline per kg diet group. Camitine concentrations in small 
intestinal tissue are shown in Figure 4-1 .  In all segments and in the whole intestine, 
there was an apparent dose dependent increase in total carnitine concentrations in 
choline supplemented animals, but was significant only in the group getting IO  g 
choline per kg diet. Differences in free or acyl camitines were not significant between 
groups. Although the differences were not significant, there was an apparent increase 
in both free and acyl camitines that, when combined, resulted in a significantly higher 
total carnitine. The carnitine concentration of the lumen contents of the small intestine 
and feces were highly variable, and there were no differences among groups {Table 4-
7) . Body composition, especially % fat, was affected more by age than by the choline 
supplement {Table 4-8). Older animals had a much higher % body fat than did the 
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Figure 4-1:  Camitine concentrations in proximal (A), middle (B), distal (C), or 
average of all segments (D) of the small intestine of guinea pigs given varied levels or 
no supplemental choline added to ground diet for 21  days. NEC = non-esterified 
camitine, ASAC = acid-soluble acyl carnitine, AIAC = acid insoluble acyl camitine, 
and Total = total camitine. All values are the group mean (n = 5) ± SEM. Significant 
difference (P < 0.05) from the control group (0 g/kg diet) by ANOV A Tukey's test 
is indicated by an asterisk. 
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Table 4-7 
Intestinal Lumen Content and Feces Concentrations of Carnitine in Guinea 
Pigs Supplemented With Varied Levels of Choline for 21 Days1 
Level of Choline 
Supplement 
NEC ASAC 
Carnitine 
AIAC 
(g/kg diet) Small Intestine Lumen Content (nmoVanimal) 
0 93 .96 ± 60.86 49.59 ± 0.55 20.66 ± 10.09 
2 41.50 ± 7.66 39.21 ± 12.23 15.32 ± 3 .60 
5 58.61 ± 21.8 55 .77 ± 1. 37 23 .25 ± 11.29 
10 65.73 ± 16.80 60.66 ± 10.02 13 .30 ± 3.69 
Feces (nmoVg) 
0 5.47 ± 15.4 0.80 ± 0.45 1.51 ± 0.95 
2 6.14 ± 1.36 1.02 ± 0.55 1.05 ± 0.03 
5 4.31 ± 1.15 1.51 ± 0.79 0.45 ± 0.19 
10 3 .30 ± 0. 69 0.53 ± 0.17 0.53 ± 0.19 
TOTAL 
164.22 ± 87.98 
96.03 ± 20.73 
134.42 ± 44.39 
139.69 ± 5.24 
7.61 ± 2.64 
8.21 ± 1.59 
6.80 ± 1.88 
4.37 ± 0.66 
1Values are expressed as means for the group (n=5) ± SEM. None of the means 
between groups are significantly different (P < 0.05) by ANOV A. 
2NEC = non-esterified carnitine, ASAC = acid-soluble acyl carnitine, AIAC = acid­
. insoluble acyl carnitine, Total = total carnitine. 
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Table 4-8 
Body Composition of Guinea Pigs Supplemented with 
Varied Levels of Choline for 21 Days1 
Moisture % 
Fat % 
Protein % 
Ash % 
Total % 
Ratio %Fat / %Protein 
Fat % 
Protein % 
Ratio %Fat I %Protein 
Fat % 
Protein % 
Ratio %Fat I %Protein 
Level of Choline Supplement (g/kg diet) 
0 2 5 10  
Both Sets of Guinea Pigs Combined (n = 5) 
60.8 ± 2.8 62.4 ± 3 .4 60.5 ± 3 .2 
16.2 ± 3.5 15.3 ± 3.6 15.6 ± 3.1 
15.4 ± 0.9 16.1 ± 0. 7 16.5 ± 0. 9 
4.3 ± 0.3 4.0 ± 0.2 4.6 ± 0.2 
96.8  ± 0.8 97. 8 ± 1 .0 97.1 ± 1 .0 
1.05 ± 0.23 0.97 ± 0.25 1 .00 ± 0.25 
First Set of Guinea Pigs (n = 2) 
24.3 
15.3 
1 .59 
24.0 
16.0 
1 .53 
23 .2 
14.6 
1.63 
Second Set of Guinea Pigs (n = 3) 
63.4 ± 3.7 
14.2 ± 3.9 
16. 1 ± 0.7 
4.7 ± 0.3 
98.4 ± 0.9 
0.91 ± 0.27 
23.5 
15.1 
1 .56 
10.8 ± I .  I 9.6 ± I .  I 10.6 ± 1 .1 8.1 ± 1 .1 
15.4 ± 1 .0 16.2 + 1 .0 1 7.7 + 1.0 16.8 + 1 .1 
0.69 ± d.02a 0.59± 0.08ab 0.60± 0.05ab 0.48-± 0.07b 
1Proximate analysis was performed on whole body homogenates of guinea pig fed 4 
levels of supplemental choline in ground commercial diet. Total % is the combined 
percentages of moisture, fat, protein, and ash for each group. Each value represents 
the mean for the group (± SEM, n = 5 for the combined data, and second set of guinea 
pigs). Different superscripts indicate significant differences by ANOVA and Tukey's 
test (P < 0.05). 
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younger animals . The % protein in the carcasses was similar between the two sets of 
animals, but the younger animals had a higher % of moisture than the older animals 
(66% vs 54%). Comparing the body composition data by ANOVA and Tukey's test 
revealed no significant differences between groups in any of the measurements of body 
composition, when the two sets of animals were considered as a whole. When the two 
sets were analyzed separately. The ratio of %fat / %protein was significantly lower in 
the animals supplemented with 10 g choline per kg diet than in the nonsupplemented 
animals in the second (younger) set of animals. However, ANOV A is problematic in 
comparing these groups. When the two sets are compared separately, there is an n of 2 
in one set and 3 in the other; normally too small to be adequate for ANOV A. When 
the two sets are combined, the variation in fat % between the two sets is so large that 
too much variation is introduced by the age effect to permit differences to be 
significant for choline supplementation. Regression analysis (Figure 4-2) was also 
used for the data from the second set of guinea pigs to determine if choline dose could 
be responsible for an apparent effect on %fat and the ratio of %fat / %protein, which 
was used as an indicator of fat/lean body mass. There was not a significant decrease in 
%fat with increasing choline supplementation (R2 = 0.23, P = 0. 1). There was a 
significant trend (R2 = 0.47, P = 0.01)  for a decrease in the ratio of %fat/%protein 
with increasing choline in the second set of animals, suggesting that the variation in 
choline dosage was responsible for 4 7% of the variation in the ratio of fat/protein. 
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Figure 4-2: Regression analysis of the effect of varied levels of choline 
supplementation on % body fat (top) and the ratio of%fat / %protein (bottom) in 
whole body homogenates of guinea pigs. 
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Total body carnitine was estimated by assaying the carcass carnitine and adding 
back the camitine from the tissues that were removed (Table 4-9). When expressed on 
a per kg body weight basis the carnitine concentration was higher in the choline 
supplemented animals, with the difference being significant in 2 of the 3 choline 
supplemented groups. When expressed on µmol/animal basis the differences were not 
significant, probably due to the large variation in animal size between the two sets. 
Camitine excretion was estimated for the study period by averaging the daily 
excretion and assuming that average to be typical for all days during the study. 
Camitine conservation was then estimated for the study period by subtracting the 
average amount excreted in the choline supplemented animals from that excreted by 
the control animals. This was compared to the average increase in total body carnitine 
for each choline supplemented group over the unsupplemented group (Table 4-9). 
The increased total body camitine accounted for approximately I 00% of the carnitine 
conserved in the animals supplemented with 2 and I O  g choline per kg diet, and about 
40% of the conserved carnitine in the group supplemented with 5 g per kg diet. 
The d 2 1  urine and plasma collections were used to further describe the effects of 
choline on renal handling of carnitine (Table 4-10). Creatinine excretion and 
clearance were not affected by choline supplementation. Carnitine clearance was 
reduced in choline supplemented groups but only significantly in the 2 g choline/kg 
diet group. Fractional tubular reabsorption was significantly increased in all of the 
choline supplemented groups. 
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Table 4-9 
Total Body Camitine and Urinary Conservation of Carnitine 
in Guinea Pigs Supplemented with Varied Levels of Choline for 21 Days1 
Total Carnitine 
Level of Choline Supplement (g/kg diet) 
0 2 5 10 
Carcass (µmol/kg bw) 372.5 ± 39.5a 494.5 ± 22.0b 403 .8  ± 20.9a 48 1 . 3  ± 23 . lb 
Carcass (µmoVanimal) 1 54.4 ± 27.9 220.7 ± 41 .9 1 79.9 ± 37.8 2 1 3 . 5  ± 58.0 
S .  Intestine (µmoVanimal) 1 .3 ± 0. 1 1 .4 ± 0.2 1 . 7 ± 0.2 1 .9 ± 0.2 
Heart (µmoVanimal) 2.7 ± 0.3 3. 5 ± 0.5 3 . 8 ± 0.7 2.6 ± 0.4 
Brain (µmoVanimal) 0.7 ± 0.2 1 .0 ± 0.2 0.8 ± 0. 1 0.9 ± 0.2 
Liver (µmoVanimal) 7.2 ± 1 .3 7. 8 ± 2.0 8 .7 ± 2.4 8.4 ± 2.8 
Kidney (µmoVanimal) 2.2 ± 0. 5 2.2 ± 0.4 2.2 ± 0.3 2.2 ± 0.4 
Muscle (µmoVanimal) 1 .4 ± 0. 1 2.0 1  ± 0.2 1 .7 ± 0.2 1 .7 ± 0.2 
Total Body Camitine 
(µmoVanimal) 169.8 ± 29.7 238.8 ± 44.9 1 98.7 ± 4 1 .3 23 1 .3 ± 6 1 . 8 
Estimated Carnitine Excretion During 
the Study (µmoVanimal) 126.8 ± 28.8  62.6  ± 23 .0 55.4 ± 1 3 . 8 64.7 ± 1 7. 1  
Estimated Carnitine Consetvation 
(µmoVanimal) 64.3 7 1 .4 62. 1 
Average Increase in Total Body 
Camitine (µmoVanimal) 69.0 28.9 6 1 .5 
Total body camitine was determined by adding total carnitine in each tissue removed 
to th� total carcass carnitine for each animal . Carnitine excretion during the study was 
estimated by averaging the 24h excretions during the experimental period and 
multiplying by 21 d. Camitine conservation was estimated by subtracting carnitine 
excretion during the experimental period in choline supplemented animals from that of 
unsupplemented animals. All values are the group mean ± SEM except for some 
estimates, for which only the values are shown. 
Different superscripts indicate significant differences by ANOV A and Tukey' s test 
(P < 0.05, n = 5). 
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Table 4-10 
Effects of Varied Levels of Choline Supplementation on Renal Excretion 
and Reabsorption of Camitine and Creatinine1 
Creatinine Excretion 
(µmoVd) 
Creatinine Clearance 
(mL/minute) 
Carnitine Clearance 
(mL/minute) 
Fractional Tubular 
Reabsorption (%) 
Level of Choline Supplement (g/kg diet) 
0 2 5 10  
1 1 0.4 ± 1 5 .2 78 .4 ± 1 7.4 1 1 0 .8  ± 22. 1 1 08.4 ± 25 .6 
0.08 ± 0.03 0.06 ± 0.02 0. 1 1  ± 0.02 0.09 ± 0.04 
0.005 ± 0.002a 0.001 ± 0.001 b 0.003 ± O.OOl ab 0.003 ± 0.002ab 
92.14 ± 1.94a 97. 92 ± 0. 29b 97.3 ± 0.25b 98.16 ± 0.55b 
1Creatinine and camitine clearances were calculated using the equation : Clearance = 
(UxfPx)V where U = urinary excretion ofx, P = plasma concentration ofx, x = 
creatinine or camitine, and V = urine flow in ml per minute. Fractional tubular 
reabsorption was calculated by the formula: 
FTR(%) = {1 - (Ucne/Pcne) (Pcreat/Ucreat)} x 100 
Where FTR = fractional tubular reabsorption, Ucne = urinary excretion of carnitine 
µmoVd), Pcne = plasma concentration of carnitine (µmol/L), Pcreat = plasma 
concentration of creatinine (µmol/L), and Ucreat = urinary excretion of creatinine 
(µmoVd). All values are shown as the group mean ± SEM. Values with different 
superscripts are significantly different by ANOVA and Tukey's test (P < 0.05, n = 5). 
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Discussion 
The first set of animals maintained their weight during the study, but did not gain 
weight, because they had reached adult weight at the onset of the study. The second 
set, on the other hand, gained 1 00-150 grams during the study. This resulted in a near 
zero feed efficiency in the adult animals, which would be expected in animals that are 
now growing. The feed efficiency the younger animals varied from a low of 0. 19  (g 
body weight/g feed) in the nonsupplemented group to a high of 0.2 1 in the animals 
supplemented with 10g choline per kg diet. Neither feed efficiency, beginning body 
weight, or final body weight were significantly different among groups. 
Urine and Plasma Carniti.nes 
Carnitine excretion, in urine, was not significantly affected by choline after 2 days 
of choline supplemented diet. The excretion in the groups supplemented with 5 and 
10  g choline per kg diet was about half that of the nonsupplemented group, but the 
carnitine excretion on day two in the group supplemented with 2 g choline per kg diet 
was nearly identical to that of the control animals, suggesting a delayed response at 
the lower dose. By day 5 of the study, there was a significantly lower camitine 
excretion in all of the choline supplemented guinea pigs, a trend that continued for the 
remainder of the study. Analysis of variance also revealed a significant increase over 
time in the urinary excretion of total carnitine and the NEC and AIAC fractions. The 
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time dependent increase in urinary carnitine excretion were prevented by choline 
supplementation, and total carnitine excretion was significantly lower on day 5 than 
day O in the highest supplemented group. In previous studies there was a significant 
increase in plasma carnitine concentration in guinea pigs. In this study, plasma 
camitine was not significantly higher in the choline supplemented groups. This may be 
due to the difference in the statistical tests and number of animals. In the previous 
studies (Daily and Sachan 1995) there were only two groups with an n of 12 and 
significance determined by a t-test. In this study there were four groups of 5 animals 
each and significance was determined by ANOVA and Tukey's test (a more 
conservative test than a t-test) (Table 4-6). When the plasma data is analyzed using 
Student-Newman-Keuls test, the difference between the nonsupplemented and 2 g 
choline/kg diet groups is significant. 
Tissue and Intestinal Carnitine 
Skeletal muscle carnitine concentrations were higher in choline supplemented 
animals and was significant in the groups supplemented with 2 and 1 0  g choline per 
kg diet. There was an apparent dose effect, with the highest carnitine concentration in 
the muscle of the guinea pigs receiving the highest choline supplement. The higher 
muscle camitine in choline supplemented animals is consistent with the previous 
studies. The muscle camitine in the group supplemented with IO g choline per kg diet 
was 129% of that in the nonsupplemented group. Muscle carnitine has been shown to 
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increase 1 0% in humans supplemented with lg/day of camitine for 6 months (Arenas 
et al 1 991), 
There was no indication of an intestinal carnitine loss in choline supplemented 
guinea pigs. It was postulated that if carnitine was being lost from the intestinal tissue, 
and not reabsorbed, this would be apparent as a decreased tissue concentration. 
Instead, there was a dose-dependent increase in carnitine concentration in small 
intestine tissue. This suggested that intestinal tissue is affected by choline 
supplementation, in a manner similar to muscle tissue. It was also postulated that if 
camitine was being lost into the lumen, then lumen camitine content of the choline 
supplemented animals would be higher. The reverse turned out to be true, the lumen 
carnitine content was highest in the control animals, although none of the differences 
were significant. The camitine content of feces were also not different. The results do 
not support the hypothesis that carnitine was being lost from the intestine or that such 
loss resulted in a compensatory decrease in urinary camitine excretion. On the 
contrary, there was an accretion of camitine in the intestinal tissue of choline 
supplemented animals. 
Body Composition 
The body composition data was complicated by the age difference in the two sets 
of guinea pigs (Table 4-8). In the older animals, fat was approximately 24% of the 
body mass, but in the younger animals only about 16%; and age had a much greater 
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affect on body fat than did choline supplementation. Nevertheless, nonsupplemented 
animals in both groups had a higher percentage of body fat and a higher fat/protein 
ratio than did the choline supplemented animals, but this was only significant for those 
supplemented with IO g choline/kg diet in the second set of younger animals. The 
otherwise lack of significance is not surprising because of the high variation due to 
age effect when both sets were combined, and the low numbers per group ( n = 2 and 
n = 3) when the sets were considered individually. A regression analysis (Figure 4-2), 
however, indicated no difference in fat percentages with increasing choline 
supplementation (P > 0.05), but a significant dose-dependent effect of choline in 
reducing the ratio of fat/protein (P = 0. 0 I )  in the younger animals. There was no 
effect of choline on body composition in the mature animals. While the evidence for 
an effect of choline supplementation in reducing body fat is intriguing, it is not strong 
enough at this point to make a final conclusion. 
The total body carnitine was approximately 29% higher, on a per kg body weight 
basis, in choline supplemented animals, confinning that the reduced carnitine 
excretion represents a choline induced carnitine conservation {Table 4-9). The 
estimates of conservation of urinary carnitine closely matched the increase in total 
body carnitine. 
Others have demonstrated that choline deficiency can cause a carnitine deficiency 
(Tsai et al. 1974) with reduced liver, muscle, and whole body carnitine. It has also 
been shown that carnitine deficiency resulting from choline deficiency impairs fatty 
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acid oxidation (Corredor et al 1 967). The unique aspect of this line of research is that 
choline supplementation, in choline sufficient humans and animals, increases tissue 
concentration and total body stores of carnitine. 
Renal Regulation of Carnitine 
The mechanism of the choline-carnitine interaction is unknown. The two best 
characterized aspects of this interaction are the decrease in carnitine excretion and 
increase in tissue accumulation of carnitine in choline supplemented animals. The 
decreased carnitine excretion is not a result of impaired kidney function since 
creatinine excretion and clearance rates are not affected in choline supplemented 
animals (Table 4- 10). Instead, the decreased urinary excretion of carnitine is a result 
of an increased fractional tubular reabsorption of carnitine in the kidney. There is no 
easy explanation for how choline causes an increase in tubular reabsorption of 
camitine. Three possible mechanisms may account for the choline induced increase in 
renal carnitine reabsorption. 1) Choline acts as a co-transport molecule that facilitates 
the reabsorption of carnitine. 2) Choline reabsorption rate is increased and that a lack 
of specificity allows carnitine, a structural analog of choline, to also be reabsorbed by 
the same mechanism. 3) The renal carnitine transport protein may be upregulated 
following choline supplementation, causing an increase in fractional tubular 
reabsorption. 
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The first possibility, that choline may act as a co-transport molecule seems 
unlikely. Choline and carnitine appear to use different transport mechanisms, since 
carnitine transport is a sodium linked process (Stadler et al . 1993) and choline is not 
(Zeisel 1 981 ). Furthermore, in studies of carnitine transport in rat renal brush-border 
membrane vesicles, choline has been shown to have no effect on carnitine transport at 
physiological concentrations. At very high concentrations of choline ( 100 mmol/L ), 
carnitine transport was inhibited by more than 50% (Stieger et al. 1 995). There is, 
therefore, little reason to suspect that a co-transport mechanism is responsible for the 
increase in renal reabsorption of carnitine in choline supplemented humans or animals. 
The second possibility, that choline supplementation might upregulate choline 
reabsorptive mechanisms is counter to what would be expected in this situation. 
Upregulation of choline reabsorption would be more likely in choline deficiency. 
There is some evidence for cross-reactivity between the two molecules, however. 
Carnitine-acetyltransferase also has weak choline acetyltransferase activity, but 
choline-acetyltransferase is not cross reactive (Sastry & Janson 1994). This type of 
interaction is suspect because of the similar structure of choline and camitine, but no 
evidence is available to support such a conclusion. 
The third possibility, that the transport mechanism for carnitine is upregulated, is 
the most plausible. Although not yet identified, there is strong evidence for the 
existence of a carnitine transport protein. Berardi et al ( 1995) expressed rat kidney 
mRNA in Xenopus laveris oocytes, which induced an increased sodium dependent 
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carnitine transport in the oocytes. There is also a well characterized inheritable defect 
in the juvenile visceral steatosis (jvs) mouse involving renal reabsorption of carnitine. 
This condition is a autosomally inherited recessive defect that, in homozygotes, 
results in a depletion of serum, liver, and muscle camitine (Hayakawa et al. 1990, 
Koizumi et al. 1988). Horiuch et al {1994) demonstrated that the primary defect in the 
jvs mouse is in the renal reabsorption system for carnitine. It has been shown that the 
administration of large amounts of carnitine can correct the consequences of the 
defect (Horiuchi et al. 1 992, Horta et al., 1 996, Uenka et al. 1 996). As of now, the 
putative camitine transport protein has not been identified, antibodies to it have not 
been produced, nor the gene cloned; therefore the study of its expression is not 
possible. The possibility that choline may in some manner increase the expression of 
this protein, however, in an attractive theory that awaits further study. 
Conclusions 
There was not a clear dose response in this study. For most measured 
parameters there were no significant differences between the lowest and highest 
supplemental doses. Only the intestinal tissue data and regression of %fat/%protein in 
the carcasses were dose dependent. This study has demonstrated, therefore, that low 
doses of choline, have a near maximal effect on carnitine conservation in guinea pigs. 
7 1  
The optimal dose, with regard to specific tissues, is still not clear since the effect was 
greatest in skeletal muscle at the higher dosages, but not in heart. 
This study also suggests that the cause of the choline induced decrease in urinary 
excretion of carnitine is, in part, related to an increase in · the renal fractional tubular 
reabsorption of carnitine; and that there is not an intestinal loss of carnitine. Finally, 
the lower %fat/%protein ratio in choline supplemented guinea pigs suggests a 
metabolic consequence of the choline-carnitine interaction. Other functional 
consequences of choline supplementation were investigated in the next study. 
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Chapter 5 
Metabolic Consequences of Choline-Carnitine 
Interactions 
Introduction 
The decreased %fat/% protein ratio of the choline supplemented guinea pigs in 
the dose response study in chapter 4 suggested that choline induced carnitine 
accretion in tissues might have metabolic consequences. Carnitine supplementation 
has been utilized in attempts to improve athletic performance in several studies ( see 
Table 5-1). Two primary issues remain unresolved from these studies . I )  Does 
carnitine supplementation increase muscle carnitine concentrations? 2) If muscle 
carnitine is increased, is the capacity for the muscle to oxidize fatty acids also 
increased? 
Severe carnitine depletion unquestionably results in a decreased capacity for fatty 
acid oxidation. Muscle fatigue and weakness is a classic symptom of carnitine 
deficiency {:worthily 1 983, Anonymous 1985). Valproic acid is a anticonvulsant drug 
know to cause camitine deficiency (Isom 1984). The effect of valproic acid therapy, 
with and without supplemental carnitine, on the oxidation of energy substrates 
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Table 5-1 
Review of Carnitine Supplementation and Exercise 
Reference 
(species) 
Carnitine Dosage 
g/d 
Duration 
days 
Arenas et al. ( 1991)  1 1 80 
(humans) 
Vukovich et al. (1 994) 9 14 
(humans) 
Gorostiaga et al. ( 1989) 2 28 
(humans) 
Wyss et al. ( 1 989) 3 25 
(humans) 
Decombaz et al ( 1993) "' 7 ., 
(humans) 
Veechiet et al ( 1990) 2 lb  prior 
(humans) to exercise 
Heinonen and Takala ( 1 994) Carnitine depleted to 
(rats) 48% of controls 
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Results 
Muscle carnitine 
increased over placebo 
treated controls 
No effect on muscle 
carnitine or fat oxidation 
RQ decreased during 
exercise in carnitine vs 
placebo supplemented 
RQ decreased during 
exercise in carnitine vs 
placebo supplemented 
No effect on RQ or on 
work capacity. 
Increased work capacity 
but no effect on RQ 
No effect on work 
capacity or fat oxidation 
has been studied in humans (Melegh 1 994). In this study 8 patients receiving valproic 
acid therapy had an average resting non protein RQ of 0.93, indicating that 
carbohydrate was the predominant energy source. With supplemental carnitine, the 
resting RQ decreased to 0.85, a more typical RQ which indicates that fat and 
carbohydrates are contributing about equally to energy demands. 
There are conflicting studies on the effects of camitine supplementation on energy 
substrate utilization in normal individuals. Vukovich et al ( 1 994) reported that 
carnitine supplementation (9g/d) for 2 weeks had no effect on either exercise 
capacity, respiratory exchange ratio (RER) during 1 h of submaximal exercise at 70% 
V02max, or muscle carnitine concentrations. However, Arenas et al. ( 1 99 1 )  
demonstrated very different effects of camitine supplementation in a 1 80 d placebo 
controlled experiment. Exercise training (long-distance running) significantly 
decreased the muscle concentration of camitine (28.0 - 26.3  µmol/g noncollagenous 
protein) in subjects given a placebo, but subjects given I g/d of carnitine had a 
significant increase in muscle carnitine (26.3 - 29.0 µmol/g noncollagenous protein) 
while participating in the same exercise routine. A similar effect was seen in sprinters. 
The different effects on muscle camitine between the two studies may be an indication 
that supplementation with smaller doses ( I vs 9 g) over a long period of time ( 1 80 vs 
7 d) is more effective than higher doses for a short time. Unfortunately, Arenas et al. 
did not determine a functional effect by measuring RER, endurance, or other possible 
indicators of changes in oxidative capacity. Other researchers have, however, 
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reported an effect of carnitine supplementation on exercise capacity and RER, but did 
not determine effects on muscle carnitine concentrations (Table 5-1). 
One recent study (Heineken and Tackle 1994) found no effect of "moderate" 
carnitine depletion in young rats on exercise capacity. In this study, the control group 
was fed a commercial pellet diet, while the carnitine devoid group was given a 
carnitine free isocaloric liquid diet. The carnitine deficient animals were given free 
access to their diet, and the control group paired with one of the camitine devoid 
animals, and food adjusted so that each rat received the same amount of nutrients, 
except camitine, in each pair. The muscle camitine concentration in the carnitine 
devoid animals was 48% of that in the control animals. The lower muscle carnitine, 
however, did not result in a reduced swimming time to exhaustion, or in a reduced 
oxidation of 14C palmitate after an 8h fast. The authors concluded that moderate 
carnitine depletion does not affect exercise capacity or fatty acid oxidation. However, 
there were several problems with this study. First the camitine assay measured only 
free and short-chain acyl carnitines. Long-chain acyl camitines were not determined. 
If there was a higher percentage of long-chain acyl carnitine in the devoid group, then 
the differences in muscle carnitine content would be correspondingly smaller. Second, 
these were young growing rats ( same age as the second set of guinea pigs in the dose 
response study), if camitine sufficiency resulted in a comparatively lower fat/lean 
body mass, as seen with choline supplemented guinea pigs, then buoyancy would be 
affected and could have a significant impact on swimming time. That is, if the 
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carnitine devoid rats had a higher % body fat, they would be more buoyant and 
require less work to swim. There was no body composition analysis in this study, 
although the carnitine deficient rats gained significantly less weight during the feeding 
period. The results of this study are difficult to interpret, and the validity of the 
author's conclusions is not possible to access without additional information. 
We have demonstrated that choline supplementation increases muscle camitine 
(Daily and Sachan 1 995) and carcass carnitine (Table 4-9) in normally fed guinea 
pigs. However we have not clearly demonstrated a functional consequence for this 
increase in muscle carnitine. The objective of this research, therefore, was to 
determine if choline induced camitine accretion in muscle increases fatty acid 
oxidative capacity and endurance in guinea pigs using indirect calorimetry under 
normal, starvation, and exercise conditions. 
Materials and Methods 
The protocol for this research was approved by the Animals Care and Use 
Committee of the Universty of Tennessee. Twenty male Hartley guinea pigs 
( SASCO, Omaha, NE) were divided into 2 groups to be fed ground commercial diet 
(Purina Guinea Pig Chow no. 5025, Purina Mills, Richmond, IN) with or without 
supplemental choline (3g/kg diet from choline chloride). It was not possible, to study 
more than two animals simultaneously, therefore, animals were ordered in pairs and 
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continued through the study as pairs, so that there would not be differences in age 
(Age = 9. 7 ± 1 .2 weeks for both groups), and minimal differences in body weight 
between groups. · The animals that began as pairs for the starvation study were then 
used in the exercise study. Animal diets, and weights are compared in Table 5-2. 
Experimental Design - Fasting Study 
This study was designed to monitor gas exchange in all animals over an 8h period 
prior to beginning the experimental diets under fed and unfed conditions and again 
after 2 weeks on the experimental diets. When animals were monitored in the unfed 
state, food was provided at 800 hours and removed at 900 hours. At 900 hours, gas 
measurements were begun and each animal was measured during each one hour 
period for 8 hours. When measurements were made during fed conditions, the animals 
had free access to food except when in the gas monitoring chamber. The following 
schedule was followed for each pair of guinea pigs. 
Week 1 - Animals monitored for gas exchange twice for 8h under fed conditions. 
Urine was collected for 24 h following the gas measurements with 
animals having free access to food. 
Week 2 - Animals monitored once for 8h with food withheld for the entire time. 
Urine was collected for 24 h following the gas measurements while 
animals still unfed. Animals were, therefore, unfed for 8 h prior to 
beginning the urine collection and 32 h at the end of the collection. 
Week 2 - Foil owing unfed experiment, animals were placed on experimental diets. 
Week 3 - Animals on experimental diets. 
Week 4 - Animals on experimental diets 
Week 5 - Animals monitored for 8h under fed conditions, as before. 
Week 6 - Animals monitored for 8h under unfed conditions as before. 
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Table 5-2 
Choline Content of Guinea Pig Diets and Initial & Final Body Weights 1 
Diets 
Choline Supplement (g/kg) 
Endogenous Choline (g/kg) 
Total Choline (g/kg) 
Animal Weights - Starvation Study 
Initial Body Weight 
Final Body Weight 
Animal Weights - Treadmill Study 
Initial Body Weight 
Final Body Weight 
Experimental Group 
(Level of Choline Supplement) 
0 
0 
1 . 85 
1 . 85 
524.8 ± 1 3 .0 
686. 1 ± 22.0 
972.6 ± 53 . 7  
1025 .3  ± 39.2 
3 
3 .0 
1 . 85 
4. 85 
502.9 ± 1 5 .4 
667.2 ± 23 . 1  
938 .8  ± 25.6  
944.9 ± 28. 1 
1Diets were prepared by grinding commercial diet and adding either no supplement or 
choline from choline chloride. Values are means for the group ± SEM for body 
weights. The same diets were continued through the starvation study and the treadmill 
study. 
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Animals were fed each morning lh prior to beginning the experiment. On days 
when food was withheld, animals were fed normally in the morning but food was 
removed when each animal was placed in the metabolic chamber. During each I h 
period, animals were placed in the sealed metabolic chamber for 20min and gases 
collected in a gas collection bag (allowed to fill for lmin) after 10, 15, & 20min. The 
02 and CO2 content of each gas collection was determined using an Ametek S-3A/1I 
oxygen analyzer and Ametek CD-3A carbon dioxide analyzer, values for the 3 
collections were averaged and the average used as the value for that I h period. 
Fed-state measurements were made twice during pre-supplement period and 
experimental diet period. There was only one day of unfed measurements for each 
dietary period, because of the possibility that the animals might not fully recover from 
being unfed more times. After each 8h gas measurement experiment, the guinea pigs 
were placed in metabolic cages (not the metabolic chamber that was used for 
calorimetry) for 24h urine collections. Either feeding or unfeeding, whichever was 
used in the gas measurements, was continued for the 24h urine collection. Urine was 
collected and frozen at -20°C for analysis of carnitine and urea nitrogen at a later 
time. 
Experimental Design - Treadmill Study 
The treadmill study was designed to evaluate choline induced changes in RER, 
V02 , and endurance during submaximal exercise. All animals were trained to run on 
80 
treadmill prior to starting the experiments. The average age of the pairs of guinea pigs 
was 8. 1 ± months, and the average time on experimental diets was 5.5 ± 0.9 months. 
Each pair was trained on the treadmill for the same length of time and at the same 
intensity to insure that no differences in training effects between groups influenced the 
outcome. Treadmill training sessions were kept to 10 minutes to minimize any 
trainining effect, since the purpose of this study was to evaluate the effect of 
supplemental choline and not training. 
There were four time periods in the experimental protocol, early morning, late 
morning, early afternoon, and late afternoon, approximately 0900, 1 1 00, 1300, 1500 
hours respectively, depending on how long the preceding animals ran. Each animal 
was rotated between time periods and performed 4 running bouts each ( except 1 
which refused to run after two bouts). 
The treadmill was set at a 5% incline with a speed of l Sm/min. This incline and 
speed was determined during trial runs to be equivalent to a "fast walk", and an 
exercise work rate that could be tolerated for extended periods. Animals were placed 
in the treadmill unit for 1 5min prior to commencement of running. Air flow through 
the unit was set at 2.1 L/min. After l 5min the first gas collection was taken and 
analyzed as in the starvation study, and the first collection designated time O. 
Immediately following the first gas collection the treadmill was started, air flow 
increased to 3. 8 L/min, and gas collected and analyzed at 5 min intervals until the end 
of the experiment. Animals continued running for 2h or until they refused to run 
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longer, preferring the electric shock to running further. All animals were given a 
minimum of 3 days recovery between exercise experiments. 
After completion of the treadmill studies the animals were allowed to remain on 
their respective diets for a minimum of 2 weeks before being killed. Four animals at a 
time were placed in metabolic cages with or without food as follows: 1 
nosupplemented-fed, 1 nonsupplemented-unfed, 1 choline supplemented-fed, 1 
choline supplemented-starved, and urine was collected for 24h. After the 24h urine 
collection the animals were anesthetized with methoxyflurane, blood taken by cardiac 
puncture, and the animals killed by decapitation. Heart, liver, brain, kidney, and 
muscle were collected for carnitine assay and frozen at -80°C. Liver and muscle tissue 
were also processed for the CPT assay which followed killing of the animals. 
Gas Analysis 
Gas analysis instruments determine the percentage of the measured gases in an air 
sample. In this case 02 and CO2 are determined and N2 assumed to be the remainder, 
a reasonable assumption (Bursztein et al. 1 989). 02 and CO2 are determined using 
the following equations. 
V02 = (VI X FI02 ) - (VE X FE02 ) 
Where: V02 = volume of oxygen utilized. 
FI02 = Fraction of oxygen entering the chamber (0.2093 for room air). 
FE02 = Fraction of oxygen exiting the chamber. 
VE and VI = the air flow in and out of the chamber and are assumed to be 
equal. 
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VC02 = (VE X FEC02 ) - (VI X FIC02 ) 
Where: VC02 = volume of carbon dioxide produced. 
FEC02 = fraction of carbon dioxide exiting the chamber. 
FIC02 = fraction of carbon dioxide entering the chamber (0.0003 for room 
air). 
VE and VI = air flow in and out of the chamber and are assumed to be equal. 
These equations, therefore, use the fraction of the gases entering and leaving the 
chamber, to determine the change in gas concentration from room air. The decrease in 
the fraction of 02 and the increase in the fraction of CO2 are both multiplied by the 
air flow per minute through the chamber to give the volume of each gas utilized or 
produced. There are two adjustments made to the basic equations above that are used 
in actual practice. 
First VE and VI are adjusted to their equivalents at standard temperature and 
pressure (STPD) from the values obtained at ambient temperature (ATPS) using the 
following equation for the conversion factor (Bursztein et al. 1989, Osborn et al. 
1969) : 
where: 
KI = 273 + 37
° C X 
BP - PAH20 
273 + T° A  BP - PH20(37
° C) 
KI = conversion factor for converting gas volume at ATPS to STPD 
273 = the absolute temperature (in degrees Kelvin) at O ° C 
BP = barometric pressure 
T0 A = the ambient temperature at which the measurements were made ( degrees C) 
P AH2 0 = the pressure of water vapor at the ambient temperature 
PH2 0 = the pressure of water vapor. 
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There is an assumption in the basic equations that because N2 is not absorbed, it 
remains constant in inspired and expired air. In actual practice there is usually a small 
difference in the percentage ofN2 between the two, and this is the second adjustment 
that is made to the basic equations. For the concentration of nitrogen to be the same 
in both inspired and expired air, the volume of CO2 added to the expired gases must 
be equal to the volume of 02 removed, in other words, there must be an RER of 1 .  
This not usually the case. Therefore, the following equations are expanded versions of 
the basic equation, and are used to adjust for this effect in calculating V02 and VC02. 
Where: 
vco = {FECO [l - FEC02-FE02J - F1co }  X AF 2 2 0.7904 2 
VO = AF x {F/0 -[FEO 
x I - FEC02-FE02 ]} 
2 2 2 0.7904 
AF = air flow through the chamber 
0.7904 = fraction ofN2 in room air 
VC02 = volume of carbon dioxide produced. 
FEC02 = fraction of carbon dioxide exiting the chamber. 
FIC02 = fraction of carbon dioxide entering the chamber (0. 0003 for room air). 
V02 = volume of oxygen utilized. 
FI02 = Fraction of oxygen entering the chamber (0.2093 for room air). 
FE02 = Fraction of oxygen exiting the chamber. 
84 
A step by step description of the indirect calorimetry measurements is available in 
appendix 2. 
Carnitine and Urea Nitrogen Assays 
Camitine was assayed using the radioenzymatic assay described in the materials 
and methods section of chapter 4 (Cederblad and Lindstedt 1972, Sachan et al 1 984). 
Urea nitrogen was determined in the urine samples using Sigma kit no. 640, a 
spectrophotometric urease/Berthelot determination for serum, plasma, or urine. In 
this assay urea is first hydrolyzed releasing ammonia. The ammonia reacts with 
alkaline hypochlorite and phenol in the presence of sodium nitroprusside ( a catalyst) 
to form indophenol. The concentration of ammonia is directly proportional to the 
absorbance of indophenol at 570 nm, and the concentration is calculated based on the 
absorption ofa standard solution of urea ( 1 0 .7 mmol/L or 30 mg/di). 
Carnitine Palmitoyltransf erase -1 Assay 
CPT-1 was assayed in intact mitochondria from muscle and liver processed 
immediately following removal from the animals. Mitochondria were prepared 
according the method of Johnson and Lardy ( 1967). The tissues were first minced by 
cutting with scissors in cold 0.25 mol/L sucrose and then homogenized using a 
Potter-Elvehjem homogenizer with a teflon pestle rotating at 125 rpm. For liver, 3 
passes on the homogenizer was used for the homogenization, additional passes were 
required for homogenization of muscle. The homogenate was then centrifuged at 600 
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x g for 1 0  minutes and the supernatant containing the mitochondria decanted into a 
second set of centrifuge tubes. The mitochondria were then centrifuged at 1 2,000 x g 
for 1 0  minutes, the pellet was then resuspended in 0.25 mol/L sucrose and centrifuged 
again at 12,000 x g for 1 0  minutes. The pellet was resuspended as before, protein 
determined by biuret assay and the mitochondrial suspension adjusted to 10mg 
protein/ml. 
The method of Bremer ( 1981)  was used to estimate CPT-1 activity in muscle and 
liver mitochondria. Each assay mixture contained in a total volume of0.5 ml : 82 
mol/L sucrose, 70 mol/L KCI, 1 mol/L EGT A, 70 mol/L imidazole, 1 µg antimycin A, 
2 mg BSA, 0.5 mol/L L-carnitine (0.4 mCi/mmol ofL-[methyJ-3H] carnitine) and 40 
µmol/L palmitoyl Co A. For determination of malonyl Co A inhibition, malonyl Co A 
concentrations were 0, 1 0, 25, and 50 µmol/L. For determination of the apparent km 
of palmitoyl CoA, concentrations were 10, 50, 1 00, and 200 µmol/L and for the 
determination ofkm for carnitine, concentrations were 0. 1 ,  0.5, 1 ,  and 2 mmol/L. 
Inhibition data was plotted in a double reciprocal manner : 1/ %inhibition on the y 
axis and I/concentration of malonyl CoA on the x axis. The reciprocal of the inhibitor 
concentration that gives 1/2 of maximum inhibition ( 1 /150 ) is at the intersection of the 
x axis and the reciprocal of the maximum inhibition (lllmax ) is at the intersection of 
the y axis. The calculations were performed with the assistance of the Hyperbolic 
Regression Analysis 1 .0 1  software (J.S. Easterby, Liverpool, UK). More details for 
the assay are available in the protocol in appendix 1 .  
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Statistics 
The urinary excretion of carnitine in fed and unfed states was analyzed using a 
split plot, repeated measures ANOV A using the MIXED procedure of SAS (Cary, 
N.C.). When the F test indicated differences between groups, the differences were 
separated using Fisher' s protected least significant difference test. Tissue camitine 
concentrations, urinary excretion and plasma concentrations of camitine, and CPT 
activity were compared using ANOV A and Student-Newman-Keuls test when the 
ANOV A indicated differences among groups. Running time between groups was 
compared using Student' s  t test. 
Results 
Fasting Study 
There was no effect of choline supplementation on either RER or oxygen 
consumption when animals were fed or when food was withheld over Sh. The Sh 
starvation did affect RER in both groups with the RER decreasing over time from 
about 0.95 to about 0.79 (Figures 5-1 & 5-2). There was an apparent effect of 
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Figure 5-1: Pre-experimental diet respiratory exchange ratios and oxygen 
consumption. These pre-experimental diet measurements compared animals that 
would in be either choline supplemented or nonsupplemented groups after starting the 
experimental diets. Values are means for the group ± SEM ( n =IO  when food 
withheld, n = 20 when fed). 
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Figure 5-2: Post-experimental diet respiratory exchange ratios and oxygen 
consumption. The animals were either choline supplemented (ChS) or non­
supplemented (NS). Values are means for the group ± SEM. There were no 
differences between NS and ChS groups but RER and oxygen consumption were 
significantly lower after 4h & 6h respectively, when food was withheld as compared 
to fed states, by ANOVA and Student-Newman-Keuls test (P s 0.05, n = 10  when 
food withheld, n = 20 when fed). 
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8 
being unfed on oxygen consumption, with oxygen consumption decreasing more over 
time when food was withheld. 
There were no differences between groups in 24h urinary excretion of camitine 
prior to starting the experimental diets. There was, however, an effect of starvation 
with both groups excreting less NEC but more ASAC and AIAC. ASAC was 
increased nearly IO fold and total carnitine excretion almost 3 fold as a result of 
starvation (Table 5-3). There was no significant effect of choline supplementation on 
urinary excretion in this study (Table 5-3). Urinary excretion of acyl and total 
carnitines was increased during starvation in both groups. There were also no 
significant differences in 24h nitrogen excretion, with 524 ± 53 and 471 ± 20 mg 
N/d/kg body weighted being excreted during the fasting state in the nonsupplemented 
and choline supplemented animals respectively. 
Treadmill Study 
The nonsupplemented and choline supplemented guinea pigs were run on a 
treadmill for either 2h or to exhaustion, whichever came first, to evaluate if the added 
stress of exercise would reveal differences in energy substrate utilization or endurance 
between the nonsupplemented and choline supplemented groups (Figure 5-3). The 
RER was not different between the nonsupplemented and choline supplemented 
groups. 
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Table 5-3 
Urinary Excretion of Camitine in Guinea Pigs With or Without Choline 
Supplement in Fed and Unfed States1 
Level of Choline 
Supplement 
and Feeding 
State NEC 
(g/kg diet) 
0 - Fed 
3 - Fed 
O - Unfed 
3 - Unfed 
0 - Fed 
3 - Fed 
0 - Unfed 
3 - Unfed 
4.5 ± 0.7a 
4.6 + 0.7a 
1 .5 + 0.3b 
1 .6  ± 0.3b 
4.8 ± 0.7a 
2.6 + 0.7a 
1 .6 + 0.2b 
2.2 ± 0.3b 
Carnitine (µmol/d) 
ASAC AIAC 
Prior to Starting Experimental Diets 
2.8 ± 0.7a 
2.8 + 0.8a 
20.8 + 2.9b 
18. 1  ± 2.0b 
0.4 ± 0. l a 
0.5 + O. l a -
b 0.8 + 0.2 
1 . 1 ± 0.3b 
While on Experimental Diets 
2.5 ± 0.5a 
1 .5 + 0.4a 
2 1 .7 + 1 .6b 
19.5 ± I . Sb 
0.4 ± 0.4a 
0.4 + O. l a 
1.5 + 0.5b 
1 .3 ± 0.4b 
TOTAL2 
8.0± 1 .oa 
7.6 ± 1 .4a 
23.4 + 3. lb 
20.6 ± 2. lb 
7.6 ± 1. la 
4.5 + 1.oa 
24.7 + I . Sb 
23.0 ± 1.7b 
1Non-supplemented animals were fed ground commercial guinea pig diet, choline 
supplemented animals were fed the same diet with 3 g/kg added choline from choline 
chloride. Food was withheld for 8h (for gas measurements) prior to placing the 
animals in the metabolic cages when unfed for 24h urine collections. When fed, the 
animals were given free access to food. Values are expressed as means ± SEM for 
the group (n=8 when animals were starved and n = 16 when fed). Different 
superscripts indicate significantly different means among groups (P < 0.05). 
2NEC = non-esterified carnitine, ASAC = acid-soluble acyl carnitine, AIAC = acid­
insoluble acyl camitine, Total = total carnitine . 
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Figure 5-3: Respiratory exchange ratio of choline supplemented (ChS) or non-supplemented (NS) guinea pigs running on a 
treadmill at a speed of 1 5  m/min and an incline of 5%. The equation for. the slope of each regression line is shown. Also 
shown is the average running time ± SEM, there was no significant difference in running time by Student 's  t test (P > 0.05). 
Final Blood, Urine, and Tissue Collections 
After the animals had completed the starvation and treadmill studies, they were 
allowed to recuperate for two ':"eeks, but remained on their respective diets. After 
recuperation, four animals (2 nonsupplemented and 2 choline supplemented) at a time 
were placed in metabolic cages and urine collected while fed or unfed ( 1 from each 
group for each treatment). After the 24h urine collection, blood and tissues were 
collected. 
Urinary excretion of acyl and total carnitines was higher in starved animals, 
indicating increased oxication of fatty acids. There was no differences in plasma total 
carnitine either between groups or as a result of starvation (Table 5-4). There was, 
however, a shift from mostly NEC to nearly equal amounts of NEC and ASAC in the 
plasma of starved animals. The excretion of carnitine was not different between the 
choline supplemented and nonsupplemented guinea pigs either during starvation or 
when fed (Table 5-4). Urinary excretion of acyl and total carnitine was significantly 
higher during starvation for both groups. 
Brain total carnitine was higher in the choline supplemented group, due primarily 
to NEC, but was only significant in the unfed animals (Table 5-5). The unfed state 
tended to decrease liver free carnitine, but only significantly so in the 
nonsupplemented group. There was also a trend toward decreased carnitine in the 
hearts of unfed animals, due primarily to a decrease in ASAC. In kidney carnitine was 
higher in fae �S animals during the fed state, but not different during starvation. 
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Table : 5-4 
Final Plasma Concentrations and Urinary Excretions of Camitine in 
Control or Choline Supplemented Guinea Pigs in Fed or Unfed States1 
Level of Choline 
Supplement 
and Feeding 
State 1'r.E:C 
(g/kg diet) 
0 - Fed 4.8 ± 1 .01 
3 - Fed 2.7 ± 1 .14 
0 - Unfed 3.4 ± 0.6 
3 - Unfed 4.3 ± 0.92 
0 - Fed 30.4 ± 3.5a 
3 - Fed 31.3 ± 4.0a 
0 - Unfed 20.5 + 1 .3b 
3 - Unfed 20.7 ± 2.4b 
Carnitine 
ASAC AIAC 
Urinary Excretion (µmol/d) 
2.1 ± 0.8a 0.4 ± O. l ab 
1.5 + 0.4a 0.2 + O.l a 
13 .8 + 2.6b 0.6 ± O.lbc 
13.3 ± 2.9b 0.7 ± 0.12c 
Plasma (µmol/L) 
9.0 ± 2.2a 2.2 ± 0.3 
8.0 + 2. la 2.0 ± 0.3 
1 7.2 + 1 .6b 2.0 ± 0.2 
1 6.7 ± 2.5b 1 .8 ± 0.2 
TOTAL2 
7.2 ± 1 . 4a 
4.4 ± 1 .3 a 
1 7.9 ± 3.3b 
1 7.7 ± 2.6b 
41 .6 ± 3.9 
41 .3 ± 5.1 
39.7 ± 1 .0 
39.2 ± 4.7 
1Non-supplemented animals were fed commercial guinea pig diet, choline 
supplemented animals were the same diet with 3 g/kg added choline from choline 
chloride. Food was withheld from half of the animals (Unfed) in each dietary 
treatment for 24h prior to killing them. The remainder were given free access to food 
(Fed). All animals had completed the exercise study at least 2 weeks before being 
killed. Values are expressed as means ± SEM for the group (n = 5 for all groups 
except n = 4 for both fed groups for urine data and choline supplemented fed group 
for plasma data). Means among groups with different superscripts are significantly 
different (P < 0.05), by Student-Newman-Keuls test. 
21'r.E:C = non-esterified carnitine, ASAC = acid-soluble acyl carnitine, AIAC = acid­
insoluble acyl carnitine, Total = total carnitine. 
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Table : 5-5 
Tissue Concentrations of Camitine in Guinea Pigs Fed Diets 
With or Without Supplemental Choline in Fed or Unfed States1 
Level of Choline 
Supplement 
Carnitine (nmol/gram wet tissue) 
and Feeding ---------------------­
State 
NEC 
(g/kg diet) 
Brain 
0 - Fed 99.4 ± 22. 5a 
3 - Fed 120.3 ± 43 . l a 
0 - Unfed 71 . 1  + 2 1 .3a 
3 - Unfed 196.6 ± 43 .4b 
Liver 
0 - Fed 338 .6 + 91 .  la 
3 - Fed 252.0 + 44.6ab 
0 - Unfed 1 86.6 + 1 7.4b 
3 - Unfed 196.6 ± 43 .4ab 
Heart 
0 - Fed 654.5 ± 90.4 
3 -Fed 744.6 ± 1 17.7 
0 - Unfed 679.3 ± 1 54.9 
3 - Unfed 593 .8  ± 96.4 
Kidney 
0 - Fed 4 1 1 .2 ± 30.3 
3 - Fed 4 1 1 . 1  ± 17.7 
0 - Unfed 478.4 ± 54.3 
3 - Unfed 457.8 ± 47. 1 
ASAC 
16.3  + 5 .3b 
30.4 ± 14.8bc 
1 . 8 ± 0.8a 
3 1 . 1 ± 5 .4c 
4.5 ± 2.6 
1 .9 ± 1 . 9 
7. 1 ± 4.9 
13 .6 ± 6. 8 
839.6 + 84.6a 
792.4 + 208.3ab 
600.3 + 106.7b 
563 . 5  ± 1 1 1 .9b 
76.8  ± 25.4a 
28.6 ± 2 1 .  7•b 
32.9 + 14.7a 
16.2 ± 8.5b 
Continued 
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AIAC 
19. 8  ± 1 . 5 
16.7 ± 5 . 1 
20.2 ± 3 .0 
1 8.2 ± 4.4 
13 . 3  ± 6.4a 
3 1 .5 ± 2.0b 
22.9 ± 6.8ab 
26.7 ± 3 .7b 
1 34. 1 ± 55 .2 
1 58.9 ± 101 . 1  
160.8 ± 1 5 .6 
167.2 ± 6 1 .6 
22. 8  ± 9.2ab 
14.o + 3 _ 5• 
22.5  + 2.0b 
24.5  ± 6.5•b 
TOTAL 
1 35 .5  + 27.6a 
167.4 ± 56. l ab 
93 . 1  + 24.4a 
245 .8 ± 39.5b 
356.4 ± 9 1 .6 
285.4 ± 43 .9 
2 16.6 ± 1 7.2 
236.8 ± 47.0 
1628.2 + 35 .2a 
1695 .9 + 259.9ab 
1440.3  + 1 39.8ab 
1324.8 ± 76.7b 
5 10.8 ± 1 1 .9b 
453 .7 ± 1 8 .2a 
555 .5 ± 47.8b 
498 .5  ± 45 .8ab 
Level of Choline 
Supplement 
and Feeding 
State NEC 
(g/kg diet) 
Skeletal Muscle 
0 - Fed 
3 - Fed 
0 - Unfed 
3 - Unfed 
454.8 + 70.9ab 
632.3 ± 1 17.8b 
377.0 ± 56.2a 
389.6 ± 91 .9• 
Table 5-5 - Continued 
Carnitine ( nmol/ gram wet tissue) 
ASAC AIAC 
223.0 ± 46.1 
272.7 ± 69.4 
208.4 ± 77.8 
320.2 ± 85.9 
54.7 ± 14.8a 
57.9 + 10_5• 
1 27.8 ± 17.2b 
1 29.3 ± 32 .0b 
TOTAL 
732.5 ± 84.4 
962.9 ± 163. 8 
71 3.1 ± 79.6 
839.1 ± 108.7 
1NEC = non-esterified camitine, ASAC = acid-soluble acyl carnitine, AIAC = acid­
insoluble acyl carnitine, Total = total carnitine. Non-supplemented animals were fed 
ground commercial guinea pig diet, choline supplemented animals were the same diet 
with 3 g/kg added choline from choline chloride. Food was withheld from half of the 
animals (Unfed) in each dietary treatment for 24h prior to killing them. The remainder 
were given free access to food (Fed). All animals had completed the exercise study at 
least 2 weeks prior to being killed. Values are expressed as means ± SEM for the 
group (n=5 except for all groups except n=4 the choline supplemented fed group). 
Means among groups with different superscripts are significantly different (P < 0.05), 
by Student-Newman-Keuls test. 
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There was a significant decrease in muscle NEC in both groups when starved. The 
muscle carnitine was not significantly different between NS and ChS animals when 
either fed or unfed. 
Carnitine Palnutoyltransf erase Studies 
Starvation increased CPT activity in the nonsupplemented animals, but not in the 
choline supplemented animals. Malonyl-CoA inhibition was determined in all samples 
as an indication of how much of the activity was due to CPT-1 as opposed to CPT-11 
(Figure 5-4). The average Imax for malonyl-CoA in the liver samples was 83%, 
indicating that most of the activity was due to CPT -1 . 
Discussion 
There was one major findings in this study; there is not an increase in fatty acid 
oxidation in choline supplemented guinea pigs, that could be revealed by a lower 
RER. This finding may be the result of three factors. First, RER may not be the best 
functio�al consequence to evaluate, although the role of carnitine in fatty acid 
oxidation is the best characterized function of carnitine. Second, guinea pigs may not 
a be good model for studying fatty acid oxidation. Third, there may be no functional 
consequence of the choline induced increase in muscle carnitine concentrations. 
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Figure 5-4: Activity ofCPT (top) in liver of non-supplemented (NS) or choline­
supplemented (ChS) guinea pigs fed or unfed for 24h. Values are means for the 
groups ± SEM. Differences were evaluated by ANOVA and Student-Newman-Keuls 
test (Ps 0.05, n = 5), different letters above bars indicate significant difference. 
Malonyl-CoA inhibition of liver CPT activity was evaluated using a double-reciprocal 
plot of malonyl-CoA inhibition as, explained in the materials and methods section. 
The curve shown here (bottom) is an example of I animal . Averages of Imax and I5o 
± SEM are shown. 
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RER as a Functional Consequence of Increased Tissue Carnitine 
The failure of choline supplementation to effect the RER in guinea pigs, under any 
conditions, seems contradictory to the body composition data presented in chapter 4. 
Of course, previous studies on the effect of camitine on athletic performance have 
been contradictory also (Table 5-1 ). There has been only one study that measured 
both muscle camitine and RER under exercise conditions in camitine supplemented 
people. That study found no effect of camitine supplementation on either muscle 
camitine or RER while exercising (Vukovich et al . 1994). However, camitine 
supplementation did increase the muscle camitine concentration in the study by 
Arenas et al ( 1991)  but neither RER during exercise nor any other functional effect of 
camitine was measured in that study. Other studies have found that camitine does 
reduce RER (Gorostiaga et al. 1989, Wyss et al 1989), and one study found that 
work capacity was increased, without an effect on RER when camitine was given 1 h 
prior to exercise (Veechiet et al 1990). If tissue carnitine does increase work 
capacity, it seems logical to assume that it does so by increasing the capacity of the 
cell to transport fatty acids into the mitochondrial matrix for oxidation . However, 
carnitine availability for fatty acid transport may not be rate limiting. It must be 
remembered that camitine functions to shuttle acyl moieties between cellular 
coenzyme-A pools. Removal of short-chain acyl groups from acyl -CoA in the 
mitochondrial matrix, thereby freeing Co-ASH, is an important function of carnitine 
and carnitine acetyltransferase (Bieber et al. 1992, Broquist 1 994). The concentration 
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of coenzyme-A in human skeletal muscle is = 10  nmol/g, whereas carnitine 
concentration is in the range of 2000 - 5000 nmol/g (Brass and Hiatt 1994). The 
intracellular carnitine pools is believed to act as a sink to help maintain an optimal 
free/acyl-CoA, which is important in the regulation of several important enzymes 
involved in intermediary metabolism, including pyruvate dehydrogenase (Bieber et al, 
1992). It has been demonstrated that, during intense exercise, there is a shift to higher 
concentrations of muscle acyl-carnitine at the expense of free camitine (Friolet, R., 
Hoppeler, H., and Krahenbuhl, S. 1 994). There is a simultaneous increase in total 
coenzyme-A, and a significant increase in the ratio of acyl/free-CoA. The implications 
of changes in free and acyl CoA are difficult to interpret from measurements of total 
tissue concentrations. It is believed that during ketotic states, the intramitochondrial 
acyl/free-CoA ratio increases whereas the cytosolic acyl/free-CoA ratio decreases 
(Bremer, J. 1983, Siess et al, 1978). It is possible that the maintenance of free CoA 
can become the limiting action of camitine during exercise, and that failure to do so 
may impair both fat and carbohydrate oxidation (Bieber et al, 1992, Sugden and 
Holness 1994). 
Because this study evaluated the effect of choline on muscle camitine, any effect 
that would affect neurmomuscular signaling might also affect running ability. 
Camitine in skeletal muscle may also have a role, through an interaction with choline, 
in the synthesis of acetylcholine. Acetylcholine is an important neurotransmitter in 
both nervous tissue and at the neuromuscular junction. Carnitine and acetylcarnitine 
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have been proposed to facilitate the production of acetylcholine in the brain, and 
carnitine acetyltransferase activity is known to be reduced in Alzheimer's disease 
(Kalaria, R.N. and Harik, S .H. 1992). In cultured neuroblastoma cells, the 
combination of choline and camitine has been demonstrated to synergistically increase 
the production of acetylcholine (W awrzenczyk et al 1994 ). Whether the combination 
of choline and carnitine in muscle cells could synergistically increase acetylcholine 
signaling at the neuromuscular junction has not yet been investigated, but this 
possibility can not be ignored as a possible functional consequence of the choline 
camitine interaction investigated here, and deserves further investigation. 
Guinea Pigs as a Model for Fatty Acid Oxidation 
How efficiently guinea pigs utilize fat as an energy substrate has not been well 
documented. The CPT- 1 activity reported here for guinea pigs is only about 25-30% 
of that reported for rat liver, using the same assay (Kashfi et al 1993). The lower 
activity can not be due to contamination with CPT-Il, since such contamination 
increases CPT activity under assay conditions. This is not surprising, since the 
reported Km for carnitine in guinea pig liver CPT-1 is 3 1 1  µmol/L, as compared to 
37µmol/L and 39µmol/L in rat liver and human fetal liver, respectively (McGarry et al. 
1 983). Guinea pig liver CPT-1 is also more sensitive to malonyl-CoA inhibition than 
rat liver (Iso = 1 .38  vs 2 .7 µmol/L). The high Km for carnitine and the greater 
10 1  
sensitivity to malony-CoA both suggest that guinea pig may not be able to utilize fat 
for energy as efficiently as rats and humans. 
The animal model may be responsible for the lack of effect on RER in this study, 
but it must be remembered that the studies in carnitine supplemented humans show 
conflicting effects on RER (Table 5-1) .  This may be due to the fact that there were 
very small differences in RER in the studies. For instance, 0. 883 vs 0.904 was 
significant in the study by Wyss et al. ( 1 990)). Nevertheless, repeating the exercise 
study in human subjects would result in better control, since running time can be better 
controlled in human subjects than in guinea pigs. 
Tissue and plasma carnitine 
Tissue carnitine concentrations tended not to be significantly different between 
groups, although there was a trend toward lower concentrations in starved animals 
which was sometimes significant. It may not be surprising that there was not a 
significantly higher muscle carnitine concentration in the choline supplemented, 
exercised animals since Arenas et al. ( 1 991) demonstrated that exercise depletes the 
muscle of camitine in humans. In this study plasma concentrations were the same 
between choline supplemented and nonsupplemented animals in contrast to higher 
plasma camitine in previous choline supplemented animals. The lack of difference in 
plasma camitine may again be due to an effect of exercise, which is similar to what 
has been seen in human studies. 
102 
Conclusions 
The lack of effect of choline supplementation on RER suggests that any possible 
functional consequences of the choline mediated increases in tissue camitine 
concentrations are independent of changes in fatty acid oxidation. Vecchiet et al. 
( 1 990) found that camitine supplementation increased work capacity without 
increasing RER in humans, therefore suggesting a functional consequence of carnitine 
that is not related to the capacity for fatty acid oxidation. There is, therefore, the 
possibility of a functional consequence of the choline induced carnitine conservation 
that has not yet been investigated. 
When feed was withheld from the animal there was and increase fatty acid 
oxidation in the guinea pigs as evidenced by the derease over 8 hours in RER and by 
the increased 24 h urinary excretion of acyl-camitines. However, there was no effect 
of choline supplementation. 
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Appendix 1 
Carnitine Palmitoyltransferase Assay 
Isolation of Mitochondria 
1 .  Prepare mitochondrial isolation mixture (MIM) - 0.25 M sucrose with l mM 
EGTA. To make I L  dissolve 85.6g sucrose and 0. 38 g EGTA in distilled water and 
adjust pH to 7.2 by adding IM tris dropwise. 
2. Remove liver from killed animal and place in a beaker with cold :MIM:, and chop 
into small pieces. 
3 .  Swirl pieces of liver to suspend blood and small particles of connective tissue and 
decant. Repeat washing with MIM until blood is removed (2-3 times). 
4. Homogenize liver using 3 passes of a Potter-Elvehjem homongenizer rotating at 
125 rpm. Transfer to I or 2 50-ml centrifuge tubes 
5 .  Centrifuge at 600 x g for IO  minutes. 
6 . Decant the supernatant containing the mitochondria into a second set of centrifuge 
tubes. Discard the pellet. 
7. Centrifuge at 12,000 x g for IO minutes. 
8. Discard supernatant and resuspend the pellet in :MIM: using a teflon stirring rod to 
loosen the pellet, then transferring to a small Potter-Elvehjem homongenizer and 
resuspend gently by hand. 
9. Recentrifuge at 1 2,000 x g for IO minuies. 
IO .  Discard the supernatant and resuspend the pellet, but bring to a total volume of 
only 3-4 ml this time. 
1 1 . Assay protein by the Biruet method and bring the mitochondrial suspension to 
I 0mg protein/ml. 
12 1  
CPT Assay 
Reagents and Solutions 
I .  lmidazole buffer (800 mmol/L): Dissolve 13 .62 g imidazole in approximately 200 
ml double-distilled water (DDW). Adjust pH to 7.12 at room temperature and 
bring to final volume of 250 ml in a volumetric flask. 
2. Stock BSA (20%): Dissolve 10 g of bovine serum albumin (BSA) in approximately 
40 ml DDW and bring to a final volume of 50 ml in a volumetric flask. 
3 .  Antimycin A: Dissolve 10 mg in 10 ml ethanol. 
4. Palmitoyl CoA (l mmol/L): Dissolve 10.42 mg of palmitoyl-CoA in 10 ml DDW. 
Note: check purity of palmitioyl CoA to be certain of adding correct amount. 
5. L-carnitine (50 mmol/L): Dissolve 98.85 mg ofL-carnitine-HCl in 10 ml DDW. 
Note: check purity of camitine to be certain of adding correct amount. 
6. [Methyl-3H]-L-carnitine: 250 µCi (1 mCi/ml) from Amersham. 
7. Perchloric Acid (1 mol/L): Add 89.7 ml of 70% perchloric acid (PCA) to a half 
filled with DDW 1 L volumetric flask and bring to volume with DDW. 
8. Saturated ammonium sulfate : Dissolve 100 g ammonium sulfate in 100 ml DDW 
and heat while stirring with a stir bar. Allow to cool and store in a bottle at room 
temperature. 
9. Sucrose (2 mol/L): Dissolve 68.46 g sucrose in 50 ml DDW and bring to volume 
in a 100 ml volumetric flask. 
10. Potassium Chloride (1 mol/L): Dissolve 7.64 g potassium chloride (KCl) in 
approximately 50 ml DDW and bring to volume in a 100 ml volumetric flask. 
11. EGTA (0.1 mol/L): Dissolve 3 .804 g EGTA in approximately 80 ml DDW, bring 
to pH 7.0 with 0.1 mol/L KOH. Bring to volume in a 100 ml volumetric flask. 
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12. Cocktail - I (250 ml) 
Imidazole (800 mM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  87. 5 ml 
Sucrose (2M) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  4 1 .0 ml 
EGTA (0. 1 M) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  10.0 ml 
Antimycin A ( I mg/ml) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1 .  0 ml 
BSA (20%) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  10.0 ml 
KCI ( IM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  70.0ml 
Adjust pH to 7.2 and bring to a volume 250 ml with distilled water. 
1 3 .  Cocktail - II 
L - Camitine (50mM) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  10.0 ml 
[ methyl 3H] L-camitine, I mCi/ml . . . . . . . . . . . . . . . . .  0. 4 ml 
Bring to a total volume of 50 ml with distilled water. 
Assay Procedure 
1 .  Add to 16 x I 00 mm test tubes - all samples should be run in duplicate 
25 µI Cocktail II 
Palmitoyl CoA According to protocol 
Other Ingredients e.g. malonyl CoA 
Distilled Water 
2. Add enzyme ( 1 50 µg liver mitochondria, 75 µg heart mitochondria) 
3 .  Incubate for 5 minutes @ 3 7°C in a shaking water bath. 
4. Add 50 µl Cocktail II and incubate for 5 minutes. For this step the number of 
samples must be small enough to complete all within time with 5- 10  second 
intervals between samples. 
5 .  Stop reaction by adding 4 ml of IN perchloric acid (PCA) and placing on ice. 
6. Centrifuge for 10  minutes at 2000 rpm. 
7. Decant and discard supernatant, add O. 4 ml IN PCA and sonicate to dissolve 
pellet. Resuspend in 4 ml IN PCA. 
8. Centrifuge 5 minutes at 2000 rpm. 
9. Decant and discard supernatant, add 0.4 ml IN PCA, and sonicate. 
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10. Add 1 .  6 ml distilled water, 0 . 1  ml saturated ammonium sulfate, & 1 .  6 ml of n­
butanol, and vortex. 
1 1 . Centrifuge for 10  minutes at 2000 rpm to separate aqueous and butanol phases. 
12 .  Remove an aliquot (0.8 ml) of the upper (butanol) layer and transfer to a 
scintillarion vial. 
1 3 .  Add 5 ml scintillation fluid, mix and count. 
Example of Assay Scheme - Running a Malonyl CoA Inhibition Curve 
Reagent (µl) Blank Row A Row B Row C Row D 
Water 325 300 275 295 299 
Cock I 125 125 125 125 1 25 
Palmitoyl CoA 0 25 25 25 25 
Malonyl CoA 0 0 25 5 1 
Mitochondria 25 25 25 25 25 
Cocktail II 25 25 25 25 25 
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Example of Tube Setup - 4 tissue sample labeled 1-4 in duplicate 
ID ID 2D 2D 3D 3D 4D 4D 
IC  I C  2C 2C 3C 3C 4C 4C 
IB IB 2B 2B 3B 3B 4B 4B 
B B IA IA 2A 2A 3A 3A 4A 4A 
B = blank, letters following numbers indicate sample # with treatment from rows in 
the treatment scheme above. 
Begin pipetting on the left with blanks and pipette Cocktail II into the tubes (with 
other ingredients already added) at 5 second intervals. When 5 minutes have lapsed 
since beginning with blanks begin adding PCA to the blank and pipette through the 
sequence at 5 second intervals. 
Calculations 
First calculate the specific activity of for camitine in cocktail II: 
Have: 50mM carnitine or 50 µmol/mL :. have 50 nmol/µL 
Determine activity by scintillation counting in disintegrations per minute (DPM). 
Example: 200,000 DPM for IOµL of cocktail II (1/5 50mM camitine ) 
I OµL of cocktail II has 2uL of 50 mM carnitine or I 00 nmol carnitine = 
200,000 DPM/1 00 nmol camitine or 2000 DPM/nmol of carnitine. 
Calculate activity by the equation: 
. . { DPMsample - DPMblank 1 } . Actzwty = x - + 5mm+ mgprotem 
SpecificActivity(DPM I nmol) 0.5 
Activity is in nmol/minute/mg protein 
1/0. 5 or 2 is a result of taking a 0 .8 ml aliquot of the 1 .6 ml butanol used for the 
extraction. 25 µL of I Omg/ml mitochondrial potein = .250 for mg protein. 
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Indirect Calorimetry - Methods 
Metabolic Basis of Indirect Calorimetry 
Because of the different oxidation states of fats, proteins, and carbohydrates; the 
oxidation of these nutrients result in different levels of 02 utilization and CO2 
production. The following discussion is based on information from the book Energy 
Metabolism, Indirect Calorimetry, and Nutrition by Bursztein et al. ( 1 989). 
The stoichiometric equations for glucose and tripalmitate demonstrate the basis 
for indirect calorimetry for the determination of relative energy substrate use. 
Glucose: C6 H12 06 + 6 02 -+ 6C02 + 6 H2 0 + Energy 
( 1 80 g) + ( 1 34.5 L} -+ (1 34.5 L) + ( 108 g) + 28 12  kJ 
Tripalmitate: Cs1 H9s 06 + 72.5  02 -+ 5 1  CO2 + 49 H2 0 + Energy 
(807 g) + ( 1625 L) -+ (1 143 L) + (883 g) + 32,036 kJ 
The respiratory quotient (RQ) of a person or animal can be used as an indicator of 
relative amounts of fat and carbohydrate oxidation. The RQ is obtained by dividing 
the CO2 produced by the amount of 02 utilized. Therefore, from the above equations 
the RQ for glucose and tripalmitate can be calculated as follows. 
Glucose: 1 34.5L CO2 + 134.5L 02 = 1 .0 
Tripalmitate: 1 1 43 . 5L CO2 + 1625L 02 = 0.703 
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Based on the RQ of expired gases, the relative amounts of fat vs carbohydrate can 
be estimated. Protein, however, contributes about 1 5% of energy needs during 
resting conditions (less during exercise) and has an RQ of about O. 8 1 .  Because of its 
midrange ofRQ and small contribution to energy, protein is frequently ignored and 
RQ expressed as a "non-protein" R. 
The term RQ for measurements in indirect calorimetry is commonly used in the 
literature, but it is technically incorrect. Oxidation of energy substrates occurs at the 
cellular level and RQ is the ratio of CO2 produced and 02 used at the cellular level, 
whereas the gases measured are those exchanged in the lungs. Gas exchange in the 
lungs is a good indicator of RQ only if body stores of 02 and CO2 do not change. 
What is actually measured is the respiratory exchange ratio (RER). Several factors 
can introduce differences between RQ and RER including: 
1 .  Hyperventilation can result in excessive loss of CO2 and a high RER (Fox et 
al. 1 988). 
2. Oxidation of fats result in a low RER, on the other had, excessive 
lipogenesis can result in a high RER, even when some fat is being oxidized, 
this is sometimes seen in patients receiving high carbohydrate TPN formulas 
(Bursztein et al. 1 989). 
3 .  Ketogenesis is a situation in which an 02 poor substrate (fat) is converted into 
02 rich substrates (ketone bodies), which can result in a low RER. If the 
ketones are rapidly oxidized they have little effect on RER, but if levels 
become high enough that they are excreted into the urine, then RER may drop 
below 0.07 (Bursztein et al. 1 989). 
4. Gluconeogenesis, like ketogenesis is a process that converts 02 poor 
substrates into 02 rich substrates and thereby utilizing oxygen, increasing 
apparent 02 utilization and lowering RER (Bursztein et al 1 989) . 
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Only rarely does the RQ or RER exceed 1 .0 or drop below 0.7. The highest RER 
ever recorded was 1 .4 which was in an over-fed goose. During periods of starvation 
the combination of gulconeogenesis and ketogenesis can cause RER to drop to about 
0.68. It is rare, however, for RER to be outside the range of 0.7 - 1 . 0. It is usually 
assumed that at 0. 7 the subject is relying almost entirely on fat for energy, at 1 . 0 
almost entirely on carbohydrate, and at 0.85 the two contribute equally to energy 
needs (Bursztein et al. 1989). 
Estimates of energy use are sometimes made from 02 utilization alone. This is 
valid when the RER of subjects or groups being compared are similar, and results in 
only a small error when dissimilar. As can be seen form the equations for glucose and 
tripalmitate, glucose will yield 20.9 1  kJ of energy per L 02 (28 1 2  kJ + 134.5 L 02 ) 
and tripalmitate 1 9.7 1  kJ of energy per L 02 (32,036 kJ + 1625 L 02 ). Comparing 
energy yield from 02 utilization alone results in only about a 6% differ�nce between 
100% fat and 1 00% carbohydrate oxidation. 
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Gas Analysis - Equipment Setup 
The gas analysis apparatus is setup as shown in Figure A-1 .  The usual procedure is to 
draw gasses through the 02 and CO2 sensors with the pump. The equipment used is: 
1. Ametek N-22M - oxygen sensor. 
2. Ametek S-3A/II - oxygen analyzer. 
3. Ametek P-61B - carbon dioxide sensor. 
4. Ametek CD-3A - carbon dioxide analyzer. 
5. Ametek R-1 - flow control. 
Caution must be observed to be certain that air lines are connected correctly. 
When unreasonable measurements occur, the air lines should be checked to be 
certain. The equipment must be set up so that adequate ventilation is available to the 
instruments to prevent overheating. It is also important that the equipment be set up 
in an area with adequate ventilation so that the ambient gas concentrations will remain 
stable. Gas values from expired air are compared to ambient gas concentrations in the 
room (normally 20.93% and 0.03% for 02 and CO2 respectively) . If the inspired 
room air changes from these values, erroneous values for gas utilization and 
production will result. The pump must be set to control the flow rate of gasses 
through the system. A flow rate of 50-300 ml/minute is acceptable, however I 00 
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Figure A-1 :  Equipment setup for gas analysis. Gasses are pulled trough the sensors by 
the pump. Heavy lines indicate gas lines except where labeled as electronic cables. 
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ml/minute is ideal for most applications. The flow rate is adjusted by turning the knob 
below the flow meter on the pump. A reading on the flow meter of approximately 
1 .25 mm corresponds to a flow rate of I 00 ml/minute. For determining reading for 
other flow rates see Figure 11-4 on page 28 of the manual for the Ametek oxygen 
analyzer. 
Equipment Maintenance 
Oxygen Analyzer 
Approximately once a week the cell restore cycle should be activated. This is 
accomplished by using a pencil or small screwdriver to push the button inside the hole 
labeled "cell restore" on the front panel of the analyzer. This should only be done 
when the unit is running and gas flowing through the unit. Normally the unit is left 
running all the time, unless it is going to be unused for a long period of time. Gas lines 
need to be checked periodically to be certain that there are no leaks and that each is 
securely in place so that no contamination from outside air is getting into the system. 
Caution must be observed to avoid allowing flammable gasses to pass through 
the system. Too much of a flammable gas could damage the analyzer when passed 
through the high temperature cell and ignited, small amounts would use oxygen for 
combustion and result in low oxygen values. 
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Carbon dioxide analyzer 
As with the oxygen analyzer, the air lines need to be regularly inspected. Once a 
month the cells on the sensor need to be cleaned. To clean the cell first tum off the 
unit and allow to cool. Then disconnect the air lines, both in and out, and flush warm 
water with a detergent through the in and out ports - both directions. Then flush both 
directions with distilled water followed by flushing with alcohol. Flow clean dry air 
through the system, with the system still turned off, for at least one hour before using. 
Note: I prefer to do both the cell restoration, and flushing operations on a Friday and 
allow the unit to run over the weekend, before using it for an experiment on Monday. 
These procedures are· the only routine maintenance for these instruments. For 
other trouble-shooting ideas and procedures, refer to the manuals. 
Startup and Calibration 
Drying tubes 
Drying tubes need to be prepared for drying gasses before entering the analyses 
equipment. Tubes made from tygon tubing with connectors are prepared for this use. 
Prior to use, tubing is cleaned by removing old desiccant and placing new glass wool 
inside the connectors. One connector is placed on one side of the tygon tubing and 
the tube filled with desiccant from the other side. After filling, a connector is used to 
close the open end of the tubing. Air is blown through the newly filled drying tube to 
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remove dust, so as to avoid contamination of the instruments. One tube can be used 
for up to 4 hours. 
Maintaining uniformly dry gasses is essential for accurate measurement of gasses, 
especially oxygen. It is possible to adjust measurements based on relative humidity, 
but drying gassed before measuring them is more convenient and the generally 
accepted practice. For a diagram of the effect of humidity on oxygen measurements 
see Figure II-3 on page 26 of the Ametek oxygen analyzer manual. 
Oxygen Analyzer 
1 .  Tum on the power at least 30 minutes prior to operation, 2 hours if possible. When 
using this instrument frequently, leave the power on all the time. 
2. Set the dial to 02%. 
3. Set the reference/unknown switch to the reference position. Allow room air to flow 
through the system in the same manner as sample air will be. Set the cell zero 
potentiometer to midrange. 
4. Tum the reference/unknown switch to unknown position and adjust the reference 
potentiometer until the display reads the correct 02% (20.93% for room air). A single 
point calibration is adequate for the oxygen meter and room air is a good choice as a 
calibration gas for indirect calorimetry. See page 22 of the Ametek oxygen analyzer 
for more information on calibration gasses. 
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Carbon dioxide analyzer 
1 .  Tum on power switch at the same time that the oxygen analyzer is turned on. 
2. Flow room air through the system in the same manner that sample gas will be 
analyzed. 
3 .  Adjust the zero potentiometer until the display reads 0.03% (the CO2% of room 
air}, if using room air. 
4. Flow a calibration gas with approximately 5% CO2 through the system, for which 
the exact concentration is known, and adjust the span potentiometer until the display 
reads the correct concentration. 
Whenever flowing gasses through the system it is imperative that the gasses 
not be forced through under pressure. This may result in a rupture of the cells 
and expensive repairs! Gas from a tank may be sampled by placing a small tube 
from the gas analyzer inside a much larger tube from the tank. The large tube must be 
large enough to allow free escape of gas from around the small tube, thereby 
preventing pressure from the tank from forcing gasses through the system. The 
system can also be checked by burning methanol in an alcohol burner. Methanol bums 
at an RQ of 0.67 and this can be used to determine if the system is working well. The 
alcohol must be burned at a very low flame to avoid overheating the chamber and 
possibly setting it on fire. Calibration gasses can also be purchased, these work well, 
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but the alcohol burner can be placed in the cage and test the whole system as it will be 
used with an animal. 
Note: These instructions are basic reminders of routine procedures. Before using 
the equipment for the first time, the manuals should be studied. 
Gas Sampling 
The most important consideration for gas sampling is that a thoroughly mixed, 
representative sample be collected. The change in gas concentration from ambient air 
to that exiting in the chamber housing the animal being studied, times the air flow rate 
is the amount of oxygen utilized and carbon dioxide produced. The basic equations 
are: 
V02 = (VI X FI02 ) - (VE X FE02 ) 
Where: V02 = volume of oxygen utilized. 
FI02 = Fraction of oxygen entering the chamber (0.2093 for room air). 
FE02 = Fraction of oxygen exiting the chamber. 
VE and VI = the air flow in and out of the chamber and are assumed to be 
equal. 
VC02 = (VE x FEC02 ) - (VI x FIC02 ) 
Where: VC02 = volume of carbon dioxide produced . 
FEC02 = fraction of carbon dioxide exiting the chamber. 
FIC02 = fraction of carbon dioxide entering the chamber (0 .0003 for room 
�- . 
VE and VI = air flow in and out of the chamber and are assumed to be equal. 
See material and methods for more details on calculations. 
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Both systems used in this dissertation research used fans to mix the gasses. This 
prevents air currents forming in the chamber and sampling of gasses that are not 
representative of the gas content of the chamber. 
Air Flow Rates: 
The concentration of gasses in the cage are affected by several factors, including: 
I) the size of the chamber, 2) the size of the animal, and 3) the flow rate of air 
through the chamber. Greater changes in the gas concentrations have the advantage 
of making small drifts in calibrations of less consequence. On the other hand, to great 
CO2 and too low 02 concentrations will introduce metabolic effects that are not 
intended. To avoid hypoxic conditions the CO2 concentration should not exceed 1%. 
In general a air flow rate of 2-3 L/minute will give the desired results. 
Setting up the dessicator chamber: 
The plastic dessicator chamber is used to measure gasses in resting animal. An air 
line is run from the oil free vacum/pressure pump to the air flow valve and then the 
glass flow meter. From the glass flow meter the air line goes to the side tube on the 
cage. The air line from the top of the cage takes the air out of the cage to a second 
flow meter which monitors the air leaving the cage to insure that adequate air is 
flowing through the chamber and that there are no major air leaks. A small loss of air 
flow is not a problem, as long as there is a positive pressure of air so that air is not 
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leaking into the chamber from the outside. The flow rate going into the chamber is 
used for calculations and only a small percentage of the air coming out of the chamber 
is used for analysis. The air coming from the second air flow meter is collected into a 
gas collection bag for analysis. 
Steps in using the dessicator chamber and treadmill: 
1 .  Place a new drying tube on the air line going to the gas analysis instruments. 
2. Calibrate the instrument after allowing dry air to flow through the instruments for 
at least 5 minutes. 
3 .  Check the gaskets on the end covers of the treadmill unit, or place gasket grease on 
the surfaces of the dessicator unit. 
4. Connect the hose from the flow meter attached to the air pump to the air inlet at 
the top of the end plate behind the fan on the treadmill, or to the tube at the side of 
the dessicator unit. 
5. Place an animal in the treadmill chamber or dessicator unit and seal. Adjust the gas 
flow rate - a lower flow rate is frequently used for the resting baseline than for 
exercising animals. 
6. Tum on the air pump and electrical shock coils on the treadmill, check the air flow 
meters to make certain that adequate air is flowing through the chamber. 
7. Allow gasses to equilibrate for 10  minutes before collecting gasses. 
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8. Collect gas by inserting hose on gas collection bag into the hole at the bottom of 
the end plate behind the fan of the treadmill from the line from the out air flow meter. 
10. Tum on treadmill while measuring gasses from non-exercising baseline collection. 
12. Close the gas bag and mix gasses in the bag by pressing and releasing the bag. 
1 3 .  Attach the bag to the drying tube leading to the analysis instruments. 
14. Allow instrument readings to stabilize for 3 0 seconds and record the values. 
1 5 .  Remove the gas bag from the drying tube and allow the instruments to re-calibrate 
to room air. Do not be too quick to adjust the instruments, the oxygen analyzer takes 
a long time to recover to the baseline readings. The CO2 readings will change more 
quickly than 02 since the gas passes through the CO2 sensor first. 
16. Remove air from the gas collection bag by attaching it to the vacum side of a 
vacum pump. 
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